KULR Technology (KULR) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 11, 2022
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Entity File Number	001-40454
Entity Registrant Name	KULR TECHNOLOGY GROUP, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-1004273
Entity Address, Address Line One	4863 Shawline Street
Entity Address, City or Town	San Diego
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92111
City Area Code	408
Local Phone Number	663-5247
Title of 12(b) Security	Common Stock
Trading Symbol	KULR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		112,746,587
Entity Central Index Key	0001662684
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 16,168,863	$ 14,863,301
Accounts receivable	1,344,972	136,326
Inventory	342,174	191,311
Inventory deposits	1,031,150	309,688
Prepaid expenses and other current assets	1,030,833	260,672
Total Current Assets	19,917,992	15,761,298
Property and equipment, net	829,111	374,475
Equipment deposits	4,465,937	2,153,950
Security deposits	58,941	58,941
Intangible assets, net	207,519	216,952
Right of use asset	378,186	665,687
Deferred offering costs	70,671	0
Total Assets	25,928,357	19,231,303
Current Liabilities:
Accounts payable	957,947	454,507
Accrued expenses and other current liabilities	1,823,148	1,163,227
Accrued issuable equity	138,240	290,721
Lease liability, current portion	218,875	262,379
Loan payable	0	155,226
Prepaid advance liability, net of discount (Note 9)	14,681,934	0
Deferred revenue	20,000	132,303
Total Current Liabilities	17,840,144	2,458,363
Lease liability, non-current portion	155,765	407,898
Total Liabilities	17,995,909	2,866,261
Commitments and contingencies (Note 12)
Stockholders' Equity
Preferred stock
Common stock, $0.0001 par value, 500,000,000 shares authorized; 107,700,085 shares issued and 107,568,923 outstanding at September 30, 2022, respectively, and 104,792,072 shares issued and outstanding at December 31, 2021	10,770	10,479
Additional paid-in capital	46,448,408	39,512,122
Treasury stock, at cost; 131,162 and 0 shares held at September 30, 2022 and December 31, 2021	(296,222)	0
Accumulated deficit	(38,230,508)	(23,157,559)
Total Stockholders' Equity	7,932,448	16,365,042
Total Liabilities and Stockholders' Equity	25,928,357	19,231,303
Series A Preferred Stock
Stockholders' Equity
Preferred stock	0	0
Series B Convertible Preferred Stock
Stockholders' Equity
Preferred stock	0	0
Series C Preferred Stock
Stockholders' Equity
Preferred stock	0	0
Series D Preferred Stock
Stockholders' Equity
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	107,700,085	104,792,072
Common stock, shares outstanding	107,568,923	104,792,072
Treasury stock, shares held	131,162	0
Series A Preferred Stock
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Convertible Preferred Stock
Preferred stock, shares authorized	31,000	31,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series C Preferred Stock
Preferred stock, shares authorized	400	400
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series D Preferred Stock
Preferred stock, shares authorized	650	650
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue	$ 1,393,185	$ 600,921	$ 2,181,230	$ 1,647,070
Cost of revenue	932,364	155,138	1,478,954	869,612
Gross Profit	460,821	445,783	702,276	777,458
Operating Expenses
Research and development	1,069,852	481,855	2,790,683	957,579
Selling, general, and administrative	4,349,373	3,104,410	12,210,458	7,320,524
Total Operating Expenses	5,419,225	3,586,265	15,001,141	8,278,103
Loss From Operations	(4,958,404)	(3,140,482)	(14,298,865)	(7,500,645)
Other (Expense) Income
Interest expense,net	(633,342)	(758)	(676,622)	(2,389)
Gain on forgiveness of PPP loan and interest	158,675		158,675
Debt redemption costs				(140,000)
Amortization of debt discount	(172,407)	0	(275,626)	(128,198)
Loss on debt extinguishment	(8,508)		(8,508)
Change in fair value of accrued issuable equity	27,401	45,600	123,121	(66,274)
Loss on foreign currency transactions		(292)		(292)
Total Other (Expense) Income, net	(628,181)	44,550	(678,960)	(337,153)
Net Loss	(5,586,585)	(3,095,932)	(14,977,825)	(7,837,798)
Net Loss Attributable to Common Stockholders	$ (5,586,585)	$ (3,095,932)	$ (14,977,825)	$ (10,462,124)
Net Loss Per Share - Basic (In dollars per share)	$ (0.05)	$ (0.03)	$ (0.14)	$ (0.11)
Net Loss Per Share - Diluted (In dollars per share)	$ (0.05)	$ (0.03)	$ (0.14)	$ (0.11)
Weighted Average Number of Common Shares Outstanding - Basic (In Shares)	105,572,820	99,018,630	104,223,378	93,816,203
Weighted Average Number of Common Shares Outstanding - Diluted (In Shares)	105,572,820	99,018,630	104,223,378	93,816,203
Series D Preferred Stock
Other (Expense) Income
Deemed dividend to preferred stockholders	$ 0	$ 0	$ 0	$ (2,624,326)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)		Series B Convertible Preferred Stock Convertible Preferred Stock	Series D Convertible Preferred Stock Convertible Preferred Stock	Amortization of restricted common stock	Additional Paid-in Capital Amortization of restricted common stock	Additional Paid-in Capital Amortization of stock options	Additional Paid-in Capital Amortization of market-based awards	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Amortization of restricted common stock	Amortization of stock options	Amortization of market-based awards	Total
Balance at Dec. 31, 2020		$ 1		$ 8,991				$ 17,355,968		$ (11,246,408)				$ 6,118,552
Balance (shares) at Dec. 31, 2020		13,972		89,908,600
Common stock issued upon conversion of Convertible Preferred Stock		$ (1)		$ 70				(69)
Common stock issued upon conversion of Convertible Preferred Stock (in shares)		(13,972)		698,600
Stock-based compensation					$ 126,625	$ 9,112	$ 130,245				$ 126,625	$ 9,112	$ 130,245
Common stock issued for services				$ 2				49,798						49,800
Common stock issued for services (in shares)				20,000
Restricted common stock issued				$ 200				(200)
Restricted common stock issued (in shares)				2,000,000
Net loss										(1,714,723)				(1,714,723)
Balance at Mar. 31, 2021				$ 9,263				17,671,479		(12,961,131)				4,719,611
Balance (shares) at Mar. 31, 2021				92,627,200
Balance at Dec. 31, 2020		$ 1		$ 8,991				17,355,968		(11,246,408)				6,118,552
Balance (shares) at Dec. 31, 2020		13,972		89,908,600
Net loss														(7,837,798)
Balance at Sep. 30, 2021				$ 10,201				31,462,955		(19,084,206)				12,388,949
Balance (shares) at Sep. 30, 2021				101,992,963
Balance at Mar. 31, 2021				$ 9,263				17,671,479		(12,961,131)				4,719,611
Balance (shares) at Mar. 31, 2021				92,627,200
Issuance of Series D Convertible Preferred Stock, Common Stock, and warrants for cash	[1]			$ 130				6,134,870						6,135,000
Issuance of Series D Convertible Preferred Stock, Common Stock, and warrants for cash (in shares)	[1]		650	1,300,000
Common stock issued upon conversion of Convertible Preferred Stock				$ 317				(317)
Common stock issued upon conversion of Convertible Preferred Stock (in shares)			(650)	3,170,730
Common stock issued upon the exercise of warrants				$ 300				3,712,200						3,712,500
Common stock issued upon the exercise of warrants (in shares)				3,000,000
Stock-based compensation					433,689	15,779	489,774				433,689	15,779	489,774
Common stock issued for services				$ 6				109,994						110,000
Common stock issued for services (in shares)				55,000
Restricted common stock issued				$ 42				(42)
Restricted common stock issued (in shares)				415,000
Net loss										(3,027,143)				(3,027,143)
Balance at Jun. 30, 2021				$ 10,058				28,567,426		(15,988,274)				12,589,210
Balance (shares) at Jun. 30, 2021				100,567,930
Common stock issued upon the exercise of warrants				$ 119				1,494,097						1,494,216
Common stock issued upon the exercise of warrants (in shares)				1,185,033
Stock-based compensation					440,333	20,516	754,207				440,333	20,516	754,207
Common stock issued for services				$ 9				186,391						186,399
Common stock issued for services (in shares)				85,000
Restricted common stock issued				$ 15				(15)
Restricted common stock issued (in shares)				155,000
Net loss										(3,095,932)				(3,095,932)
Balance at Sep. 30, 2021				$ 10,201				31,462,955		(19,084,206)				12,388,949
Balance (shares) at Sep. 30, 2021				101,992,963
Balance at Dec. 31, 2021				$ 10,479				39,512,122		(23,157,559)				16,365,042
Balance (shares) at Dec. 31, 2021				104,792,072
Treasury stock held upon the vesting of restricted common stock									$ (439,728)					(439,728)
Treasury stock held upon the vesting of restricted common stock (in shares)									194,704
Common stock issued upon the exercise of warrants				$ 7				87,672						87,679
Common stock issued upon the exercise of warrants (in shares)				70,143
Common stock issued upon the exercise of options								5,075						5,075
Common stock issued upon the exercise of options (in shares)				2,500
Stock-based compensation					519,231	15,883	730,048				519,231	15,883	730,048
Common stock issued for services				$ 1				43,159						43,160
Common stock issued for services (in shares)				6,000
Net loss										(4,136,555)				(4,136,555)
Balance at Mar. 31, 2022				$ 10,487				40,913,190	$ (439,728)	(27,294,114)				13,189,835
Balance (shares) at Mar. 31, 2022				104,870,715					194,704
Balance at Dec. 31, 2021				$ 10,479				39,512,122		(23,157,559)				$ 16,365,042
Balance (shares) at Dec. 31, 2021				104,792,072
Treasury stock issued upon the exercise of options									$ 48,382
Treasury stock issued upon the exercise of options (in shares)									63,542					66,042
Net loss														$ (14,977,825)
Balance at Sep. 30, 2022				$ 10,770				46,448,408	$ (296,222)	(38,230,508)				7,932,448
Balance (shares) at Sep. 30, 2022				107,700,085					131,162
Balance at Mar. 31, 2022				$ 10,487				40,913,190	$ (439,728)	(27,294,114)				13,189,835
Balance (shares) at Mar. 31, 2022				104,870,715					194,704
Treasury stock issued upon the exercise of options									$ 74,529	(46,305)				28,224
Treasury stock issued upon the exercise of options (in shares)									(33,000)
Common stock issued upon the exercise of warrants				$ 234				2,932,922						2,933,156
Common stock issued upon the exercise of warrants (in shares)				2,346,525
Stock-based compensation					422,128	26,535	565,421				422,128	26,535	565,421
Common stock issued for services				$ 1				10,260						10,261
Common stock issued for services (in shares)				6,000
Net loss										(5,254,685)				(5,254,685)
Balance at Jun. 30, 2022				$ 10,722				44,870,456	$ (365,199)	(32,595,104)				11,920,875
Balance (shares) at Jun. 30, 2022				107,223,240					161,704
Treasury stock issued upon the exercise of options									$ 68,977	(48,819)				$ 20,158
Treasury stock issued upon the exercise of options (in shares)									(30,542)					30,542
Common stock issued pursuant to the SEPA agreement, For cash, net of issuance costs	[2]			$ 16				247,855						$ 247,871
Common stock issued pursuant to the SEPA agreement, For cash, net of issuance costs (in shares)	[2]			160,782
Common stock issued pursuant to the SEPA agreement, In satisfaction of notes payable				$ 9				149,991						150,000
Common stock issued pursuant to the SEPA agreement, In satisfaction of notes payable (in shares)				94,458
Common stock issued pursuant to the SEPA agreement, For the repayment of prepaid advances				$ 22				274,635						274,658
Common stock issued pursuant to the SEPA agreement, For the repayment of prepaid advances (in shares)				221,605
Stock-based compensation					$ 403,812	$ 23,959	$ 477,700				$ 403,812	$ 23,959	$ 477,700
Net loss										(5,586,585)				(5,586,585)
Balance at Sep. 30, 2022				$ 10,770				$ 46,448,408	$ (296,222)	$ (38,230,508)				$ 7,932,448
Balance (shares) at Sep. 30, 2022				107,700,085					131,162
[1]Represents relative fair value of preferred stock issued, net of cash issuance costs of $365,000.[2]Represents gross proceeds of $250,000 less $2,129 for amortization of issuance costs.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)	3 Months Ended
	Sep. 30, 2022	Jun. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Gross proceeds of common stock issued pursuant to the SEDA agreement	$ 250,000
Amortization of issuance costs	$ 2,129
Net of cash issuance costs		$ 365,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net loss		$ (14,977,825)	$ (7,837,798)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount		275,626	128,198
Non-cash lease expense		143,861
Loss on extinguishment of note payable		8,508
Depreciation and amortization expense		140,829	29,166
Gain on forgiveness of PPP loan and interest		(158,675)
Change in fair value of accrued issuable equity		(123,121)	66,274
Non-cash interest expense		576,932
Stock-based compensation		3,208,778	2,765,959
Changes in operating assets and liabilities:
Accounts receivable		(1,208,646)	(494,887)
Inventory		(150,863)	(135,314)
Prepaid expenses and other current assets		(741,937)	(300,288)
Inventory deposits		(721,462)
Security deposits			(50,213)
Right of use asset			84,702
Accounts payable		377,987	(1,806)
Accrued expenses and other current liabilities		248,301	294,334
Lease liability		(151,997)	(82,079)
Deferred revenue		(112,303)	138,816
Total Adjustments		1,611,818	2,442,862
Net Cash Used In Operating Activities		(13,366,007)	(5,394,936)
Cash Flows From Investing Activities:
Equipment deposits for property and equipment		(2,198,626)	(1,029,805)
Purchases of property and equipment		(573,942)	(357,059)
Net Cash Used In Investing Activities		(2,772,568)	(1,386,864)
Cash Flows from Financing Activities:
Proceeds from the SEPA		247,871
Net proceeds from the prepaid advance liability	[1]	10,573,068
Issuance costs on prepaid advance liability		(85,000)
Proceeds from note payable	[2]	4,750,000
Note payable issuance costs		(17,200)
Repayments of note payable		(1,000,000)	(2,450,000)
Payment of financing costs incurred in connection with the SEPA		(72,800)
Payment of financing costs incurred in connection with note payable		2,129
Proceeds from the sale of Series D convertible preferred stock, common stock and warrants			6,500,000
Proceeds from the exercise of options		25,233
Proceeds from the exercise of warrants		3,020,836	5,206,716
Payment of financing costs			(365,000)
Net Cash Provided By Financing Activities		17,444,137	8,891,716
Net Increase In Cash		1,305,562	2,109,916
Cash - Beginning of Period		14,863,301	8,880,140
Cash - End of Period		16,168,863	10,990,056
Cash paid during the period for:
Interest		676,281	735
Non-cash investing and financing activities:
Right of use asset for lease liability		143,640	814,817
Additions to property and equipment included in accounts payable		125,451
Common stock held in treasury upon the vesting of restricted common stock		(439,728)
Common stock issued in satisfaction of accrued issuable equity			209,200
Prepaid advance for repayment of note payable		3,850,000
Shares issued in satisfaction of note payable		150,000
Shares issued in satisfaction of prepaid advance liability and accrued interest		274,658
Treasury stock issued upon the exercise of stock options		$ 143,506
Series B Convertible Preferred Stock
Non-cash investing and financing activities:
Common stock issued upon the conversion			70
Series D Convertible Preferred Stock
Non-cash investing and financing activities:
Beneficial conversion feature on Series D convertible preferred stock			2,624,326
Common stock issued upon the conversion			$ 317
[1] Consists of principal of $15,000,000 on prepaid advance liability, less $3,850,000 and $566,932 withheld to repay note payable and related interest and premiums, respectively, owed to same investor, and $10,000 withheld for issuance costs. Note payable face of $5,000,000 , less $250,000 original issue discount.

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	9 Months Ended
	Sep. 30, 2022 USD ($)
Prepaid advance liability, principal amount	$ 15,000,000
Prepaid advance liability, withheld to repay note payable	3,850,000
Prepaid advance liability, interest and premiums	566,932
Prepaid advance liability, withheld for issuance costs	10,000
Promissory Note
Initial principal amount	5,000,000
Original issue discount	$ 250,000

ORGANIZATION, NATURE OF OPERATI

ORGANIZATION, NATURE OF OPERATIONS AND RISKS AND UNCERTANTIES	9 Months Ended
	Sep. 30, 2022
ORGANIZATION, NATURE OF OPERATIONS AND RISKS AND UNCERTANTIES
ORGANIZATION, NATURE OF OPERATIONS AND RISKS AND UNCERTANTIES	NOTE 1 ORGANIZATION, NATURE OF OPERATIONS AND RISKS AND UNCERTANTIES Organization and Operations KULR Technology Group, Inc., through its wholly-owned subsidiary, KULR Technology Corporation (collectively referred to as “KULR” or the “Company”), develops and commercializes high-performance energy management technologies for electronics, batteries, and other components across a range of applications. Currently, the Company is focused on targeting both high performance aerospace and Department of Defense (“DOD”) applications, such as space exploration, satellite communications, and underwater vehicles, and applying them to mass market commercial applications, such as lithium-ion battery energy storage, electric mobility, 5G communication, cloud computer infrastructure, consumer and industrial devices. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related disclosures as of December 31, 2021 and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on March 28, 2022. Reclassifications Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. Certain prior quarter activity reported in the Condensed Consolidated Statement of Changes in Stockholders’ Equity has been reclassified in order to conform to the current quarter presentation. These reclassifications had no effect on previously reported results of operations or loss per share. Risks and Uncertainties In March 2020, the World Health Organization declared COVID-19, a novel strain coronavirus, a pandemic. During 2020 and continuing into 2022, the global economy has been, and continues to be, affected by COVID-19. While the Company continues to see signs of economic recovery as certain governments begin to gradually ease restrictions, provide economic stimulus and accelerate vaccine distribution, the rate of recovery on a global basis has been affected by resurgence of the virus or its variants in certain jurisdictions. For example, in response to an outbreak of infection in Shanghai, beginning in March 2022, governmental authorities in China implemented a lockdown order in that city, significantly slowing economic and business activity in that region and adversely affecting our ability to import product material required to fulfill some customer commitments. We continue to monitor the rapidly evolving situation and guidance from international and domestic authorities and may take additional actions based on their recommendations and requirements or as we otherwise see fit to protect the health and safety of our employees, customers, partners and suppliers. The full extent of the future impact of COVID-19 on the Company’s operations and financial condition is uncertain. Accordingly, COVID-19 could have a material adverse effect on the Company’s business, results of operations, financial condition and prospects during 2022 and beyond, including the demand for its products, interruptions to supply chains, ability to maintain regular research and development and manufacturing schedules as well as the capability to meet customer demands in a timely manner. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Since the date of the Annual Report on Form 10-K for the year ended December 31, 2021, there have been no material changes to the Company’s significant accounting policies, except as disclosed in this note. Liquidity On May 13, 2022, the Company entered into a Standby Equity Purchase Agreement, which gives the Company the right, but not the obligation, to sell up to $50,000,000 of its shares of common stock to the same investor during the commitment period. Further, on September 23, 2022, the Company entered into the Supplemental SEPA, pursuant to which the Company may request advances (“Prepaid Advances”) up to an aggregate of $50,000,000 from Yorkville. Yorkville has the right to receive shares, and may select the timing and delivery of such shares, in an amount up to the balance of the Prepaid Advance in order to pay down the Prepaid Advance liability. During the period ended September 30, 2022, the Company received aggregate gross proceeds of $15,400,000 under the SEPA and the Supplemental SEPA. The Company is not permitted to initiate additional sales of its common stock under the SEPA until the Prepaid Advance liability ($15,539,474 at September 30, 2022) is settled. During October 2022, the Company issued 5,153,664 shares of common stock, at purchase prices per share ranging from $0.99 to $1.84, in satisfaction of the initial Prepaid Advance liability in the aggregate amount of $5,750,000. As of November 14, 2022, the remaining balance on the initial Prepaid Advance liability is $9,000,000. See Note 9 – Prepaid Advance Liability and Note 11 – Stockholders’ Equity for additional information. As of September 30, 2022, the Company had cash of $16,168,863 and working capital of $2,077,848. During the nine months ended September 30, 2022, the Company incurred a net loss of $14,977,825 and used cash in operations of $13,366,007. While the Company anticipates it will continue to incur operating losses and use cash in operating activities for the foreseeable future, the Company believes that its current working capital, combined with the cash availability pursuant to the Standby Equity Purchase Agreement, is sufficient in comparison to its anticipated cash usage for a period of at least twelve months after the filing date of these financial statements. Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these unaudited condensed consolidated financial statements include, but are not limited to, fair value calculations for prepaid advance liability, equity securities, stock-based compensation and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates. Treasury Stock The Company records repurchases of its own common stock at cost. Repurchased common stock is presented as a reduction of equity in the Consolidated Balance Sheets. Subsequent reissuances of treasury stock are accounted for on a weighted average cost basis. Differences between the cost of treasury stock and the re-issuance proceeds are charged to additional paid-in capital. Gains on the reissuance of treasury stock are credited to additional paid in capital. Losses resulting from the reissuance of treasury stock are debited to additional paid-in capital to the extent previous net gains from such reissuances are included in additional paid-in capital; any losses in excess of that amount are then charged to retained earnings. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, accounts receivable, revenue and accounts payable. Cash Concentrations A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were uninsured balances of $15,668,863 and $14,363,301 as of September 30, 2022 and December 31, 2021, respectively. Customer and Revenue Concentrations The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company's total accounts receivable, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenues ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ ​ ​ ​ ​ September 30, ​ September 30, ​ As of As of ​ 2022 2021 2022 2021 September 30, 2022 ​ December 31, 2021 Customer A * ​ 88 % * ​ 41 % * ​ 42 % Customer B 67 % * ​ 58 % * ​ 70 % * ​ Customer C 24 % * ​ 23 % * ​ 25 % * ​ Customer D * ​ * ​ * ​ 40 % * ​ * ​ Customer E * ​ * ​ * ​ * ​ * ​ 21 % Customer F * ​ * ​ * ​ * * ​ 34 % Total 91 % 88 % 81 % 81 % 95 % 97 % * Less than 10% ​ There is no assurance the Company will continue to receive significant revenues from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers. Vendor Concentrations Vendor concentrations are as follows for the three and nine months ended September 30, 2022 and 2021, respectively: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, September 30, ​ ​ 2022 2021 2022 2021 ​ Vendor A 65 % * ​ 83 % * ​ Vendor B * ​ 10 % * 42 % Vendor C * ​ * ​ * ​ 47 % ​ 65 % 10 % 83 % 89 % * Less than 10% ​ Inventory Inventory is comprised of carbon fiber velvet (“CFV”) thermal interface solutions and internal short circuit batteries, which are available for sale. Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. The cost of inventory that is sold to third parties is included within cost of sales and the cost of inventory that is given as samples is included within operating expenses. The Company periodically reviews for slow-moving, excess or obsolete inventories. Products that are determined to be obsolete, if any, are written down to net realizable value. Inventory at September 30, 2022 and December 31, 2021 was consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2022 ​ 2021 Raw materials ​ $ 61,388 ​ $ — Work-in-process ​ ​ 70,195 ​ ​ 5,500 Finished goods ​ 210,591 ​ 185,811 Total inventory ​ $ 342,174 ​ $ 191,311 ​ Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer; ● Step 2: Identify the performance obligations in the contract; ● Step 3: Determine the transaction price; ● Step 4: Allocate the transaction price to the performance obligations in the contract; and ● Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: ● Product sales – Revenue is recognized at the point in time the customer obtains control of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. ● Contract services – Revenue is recognized at the point in time that the Company satisfies its performance obligation under the contract, which is generally at the time the services are fulfilled and/or accepted by the customer. The following table summarizes the Company’s revenue recognized in its consolidated statements of operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Product sales ​ $ 1,369,857 ​ $ 600,921 ​ $ 2,100,120 ​ $ 1,356,530 Contract services ​ 23,328 ​ — ​ 81,110 ​ 290,540 Total revenue ​ $ 1,393,185 ​ $ 600,921 ​ $ 2,181,230 ​ $ 1,647,070 ​ As of September 30, 2022 and December 31, 2021, respectively, the Company had $20,000 and $132,303 of deferred revenue, respectively, from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract, or the customers have not officially accepted the goods or services provided under the contract. During the three and nine months ended September 30, 2022, the Company recognized $0 and $112,303, respectively, that was included in deferred revenue in a previous period. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods. As of September 30, 2022 and December 31, 2021, the Company had $8,535 and $84,324, respectively, of deferred labor costs, which is included in prepaid expenses and other current assets in the Company’s unaudited condensed consolidated balance sheets. Deferred labor costs represent costs to fulfill the Company’s contract service revenue. The Company will recognize the deferred labor costs as cost of revenues at the point in time that the Company satisfies its performance obligation under the respective contract, which is generally at the time the services are fulfilled and/or accepted by the customer. Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. ​ The following table presents the computation of basic and diluted net loss per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ ​ 2022 2021 ​ 2022 2021 Numerator: ​ ​ ​ ​ Net income (loss) ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (7,837,798) Deemed dividend to Series D preferred stockholders ​ ​ — ​ ​ — ​ ​ — ​ ​ (2,624,326) Net loss attributable to common stockholders ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (10,462,124) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted-average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 107,402,727 ​ 101,548,848 ​ 106,271,765 ​ 95,641,862 Less:Treasury shares purchased ​ (131,494) ​ — ​ (122,944) ​ — Less:Unvested restricted shares ​ (1,948,370) ​ (2,530,217) ​ (2,106,923) ​ ​ (1,825,659) Add:Accrued issuable equity ​ ​ 249,957 ​ ​ — ​ ​ 181,480 ​ ​ — Denominator for basic and diluted net loss per share ​ ​ 105,572,820 ​ ​ 99,018,630 ​ ​ 104,223,378 ​ ​ 93,816,203 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.05) ​ $ (0.03) ​ $ (0.14) ​ $ (0.11) ​ ​ The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ 2022 2021 Unvested restricted stock ​ 1,897,500 ​ 2,615,000 Unvested market -based equity awards ​ 3,000,000 ​ 3,000,000 Options 510,216 590,000 Warrants ​ 2,524,410 ​ 5,202,878 Total 7,932,126 11,407,878 ​ Recently Adopted Accounting Pronouncements In October 2020, the FASB issued ASU 2020-10 “Codification Improvements”, which improves consistency by amending the Codification to include all disclosure guidance in the appropriate disclosure sections and clarifies application of various provisions in the Codification by amending and adding new headings, cross referencing to other guidance, and refining or correcting terminology. The guidance is effective for the Company beginning in the first quarter of fiscal year 2022 with early adoption permitted. The Company adopted ASU 2020-10 effective January 1, 2022 and its adoption did not have a material impact on its condensed consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 and its adoption did not have a material impact on its condensed consolidated financial statements.

INVENTORY DEPOSITS

INVENTORY DEPOSITS	9 Months Ended
	Sep. 30, 2022
INVENTORY DEPOSITS
INVENTORY DEPOSITS	NOTE 3 INVENTORY DEPOSITS Inventory deposits consists of amounts paid in advance to vendors to secure future deliveries of specific finished goods and raw materials which will be received and sold in future periods. As of September 30, 2022 and December 31,2021, the Company had outstanding inventory deposits of $1,031,150 and $309,688, respectively.

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	9 Months Ended
	Sep. 30, 2022
PREPAID EXPENSES AND OTHER CURRENT ASSETS
PREPAID EXPENSES AND OTHER CURRENT ASSETS	NOTE 4 PREPAID EXPENSES AND OTHER CURRENT ASSETS As of September 30, 2022 and December 31, 2021, prepaid expenses and other current assets consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ 2022 2021 Marketing ​ $ 650,766 ​ $ 10,231 Vendor receivables ​ ​ 100,000 ​ ​ — Other ​ ​ 98,535 ​ ​ 31,074 Professional fees ​ ​ 83,711 ​ ​ 65,118 Subscriptions ​ ​ 47,217 ​ ​ — Insurance ​ ​ 42,069 ​ ​ 69,925 Deferred labor costs ​ ​ 8,535 ​ ​ 84,324 Total prepaid expenses and other current assets ​ $ 1,030,833 ​ $ 260,672 ​ Prepaid marketing costs primarily consist of two sponsorship agreements with a marketing partner whereby the Company is required to make upfront payments. These agreements expire in December 2022 and December 2023. As of September 30, 2022, total prepayments made towards such contracts were $2,150,000, of which $575,000 remains unamortized and is included in prepaid marketing costs. See Note 12 – Commitments and Contingencies for additional information.

EQUIPMENT DEPOSITS

EQUIPMENT DEPOSITS	9 Months Ended
	Sep. 30, 2022
EQUIPMENT DEPOSITS
EQUIPMENT DEPOSITS	NOTE 5 EQUIPMENT DEPOSITS The Company entered into agreements with third party contractors for facility improvements, the design and build of a battery packaging and inspection automation system, and automated robotic tending system. As of September 30, 2022 and December 31,2021, the Company had outstanding deposits of $4,465,937 and $2,153,950, respectively, in connection with these agreements.

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	9 Months Ended
	Sep. 30, 2022
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	NOTE 6 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES As of September 30, 2022 and December 31, 2021, accrued expenses and other current liabilities consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Legal and professional fees ​ $ 1,088,561 ​ $ 418,154 Payroll and vacation ​ ​ 435,246 ​ ​ 302,101 Research and development ​ ​ 169,497 ​ ​ 146,158 Other ​ ​ 105,803 ​ ​ 84,824 Board compensation ​ 24,041 ​ 45,680 Accrued cost of sales ​ ​ — ​ ​ 128,500 Marketing and advertising fees ​ ​ — ​ ​ 37,810 Total accrued expenses and other current liabilities ​ $ 1,823,148 ​ $ 1,163,227 ​

ACCRUED ISSUABLE EQUITY

ACCRUED ISSUABLE EQUITY	9 Months Ended
	Sep. 30, 2022
ACCRUED ISSUABLE EQUITY
ACCRUED ISSUABLE EQUITY	NOTE 7 ACCRUED ISSUABLE EQUITY A summary of the accrued issuable equity activity during the nine months ended September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended ​ September 30, 2022 Beginning Balance ​ $ 290,721 Additions ​ ​ 62,640 Cancelled accrued issuable equity obligations ​ ​ (92,000) Mark-to market ​ ​ (123,121) Ending Balance ​ $ 138,240 ​ During the nine months ended September 30, 2022, the Company entered into certain contractual arrangements for services in exchange for a fixed number of shares of common stock of the Company. On the respective dates the contracts were entered into, the estimated fair value of the shares to be issued was an aggregate of $62,640. During the nine months ended September 30, 2022, the Company cancelled certain of its accrued issuable equity obligations of an aggregate of 33,333 of its shares, respectively, with an aggregate fair value of $92,000, respectively, due to a reduction in investor relation services. During the nine months ended September 30, 2022, the Company recorded an aggregate of $123,121 of gains related to the reduction in fair value of accrued issuable equity (see Note 11 – Stockholders’ Equity, Stock-Based Compensation

LEASES

LEASES	9 Months Ended
	Sep. 30, 2022
LEASES
LEASES	NOTE 8 LEASES The Company leases office space in San Diego, California. During the three and nine months ended September 30, 2022, operating lease expense was $57,522 and $188,854, respectively. During the three and nine months ended September 30, 2021, operating lease expense was $89,305 and $144,765, respectively. As of September 30, 2022, the Company did not have any financing leases. Maturities of lease liabilities as of September 30, 2022 were as follows: ​ ​ ​ ​ ​ Maturity Date ​ ​ October 1 through December 31, 2022 ​ $ 57,499 2023 ​ 234,694 2024 ​ 99,187 Total lease payments ​ 391,380 Less: Imputed interest ​ (16,740) Present value of lease liabilities ​ 374,640 Less: current portion ​ (218,875) Lease liabilities, non-current portion ​ $ 155,765 ​ The Company paid a security deposit of $50,213 in connection with the new lease agreement. ​ Supplemental cash flow information related to the lease was as follows: ​ ​ ​ ​ ​ ​ For the Nine Months Ended ​ September 30, 2022 Cash paid for amounts included in the measurement of lease liabilities ​ ​ ​ Operating cash flows from operating lease ​ $ 143,861 ​

PREPAID ADVANCE LIABILITY

PREPAID ADVANCE LIABILITY	9 Months Ended
	Sep. 30, 2022
PREPAID ADVANCE LIABILITY
PREPAID ADVANCE LIABILITY	NOTE 9 PREPAID ADVANCE LIABILITY On September 23, 2022, the Company entered into a Supplemental Agreement (the “Supplemental Agreement”) to its Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, Ltd. (“Yorkville”). Under the Supplemental Agreement, the Company may from time to time request advances of up to $15,000,000 (each, a “Prepaid Advance”) from Yorkville with a limitation on the aggregate amount of such advances of $50,000,000. At any time that there is a balance outstanding under a Prepaid Advance, the Company is not permitted to deliver Advance Notices (as defined in Note 11, Stockholders’ Equity) under the SEPA. Each Prepaid Advance matures 12 months after the date of the closing of such advance (the “Prepaid Advance Date”), and accrues interest at 10% per annum, subject to an increase to 15% per annum upon events of default as defined. Any Prepaid Advance balance that remains outstanding at maturity must be repaid in cash. Pursuant to the terms of the Supplemental Agreement, Yorkville has the right to receive shares to pay down Prepaid Advances, and may select the timing and delivery of such shares (via an “Investor Notice”), in an amount up to the balance of the Prepaid Advance at a price equal to the lower of (a) 135% of the volume weighted average price (“VWAP”) of the Company’s common stock on the day immediately prior the closing of the Prepaid Advance, or (b) 95% of the lowest VWAP during the three days immediately prior to the Investor Notice. The Company may prepay amounts owed for a Prepaid Advance in cash, provided that the Company gives Yorkville 10 days’ notice of its intent to repay in cash (the “Prepayment Notice”) and provided that the daily VWAP of the Company’s common stock on the date of Prepayment Notice is not less than $0.75. The prepayment amount will be delivered on the 11 th Upon the occurrence of certain triggering events, as defined, the Company may be required to make monthly repayments of amounts outstanding under a Prepaid Advance, with each monthly repayment to be in an amount equal to the sum of (x) $3.0 million, (y) 5% (the “Payment Premium”) in respect of such amount, and (z) all outstanding accrued and unpaid interest in respect of such Prepaid Advance as of each payment date. On September 23, 2022, the Company recorded an initial Prepaid Advance liability in the amount of $15,000,000, which consisted of $15,000,000 of gross cash proceeds (the “Initial Advance”), plus an original issue discount of $789,474. The original issue discount was recorded as a debt discount to be amortized ratably over the term of the Initial Advance. Of the $15,000,000 Initial Advance amount, $3,850,000 was used to repay amounts due under a Note Purchase Agreement with Yorkville (see Note 10, Notes and Loans Payable). On September 29, 2022, the Company issued 221,605 shares of common stock as a partial repayment of the Initial Advance principal amount of $250,000 and interest in the amount of $24,658. See Note 13, Subsequent Events for details related to shares issued in satisfaction of the Initial Advance subsequent to September 30, 2022. A summary of the Prepaid Advance liability during the nine months ended September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Amount of Less: Prepaid Advance ​ ​ Prepaid Advance ​ Debt ​ Liability, net of ​ ​ Liability ​ Discount ​ discount Balance, January 1, 2022 ​ $ — ​ $ — ​ $ — Proceeds from prepaid advance ​ 15,000,000 ​ — ​ 15,000,000 Original issue discount ​ 789,474 ​ (789,474) ​ — Legal fees ​ ​ — ​ ​ (85,000) ​ ​ (85,000) Repayments in cash ​ ​ — ​ ​ — ​ ​ — Repayments in shares of common stock ​ (250,000) ​ — ​ (250,000) Amortization of debt discount ​ ​ — ​ ​ 16,934 ​ ​ 16,934 Outstanding, September 30, 2022 ​ $ 15,539,474 ​ $ (857,540) ​ $ 14,681,934 ​

NOTES AND LOANS PAYABLE

NOTES AND LOANS PAYABLE	9 Months Ended
	Sep. 30, 2022
NOTES AND LOANS PAYABLE
NOTES AND LOANS PAYABLE	NOTE 10 NOTES AND LOANS PAYABLE Note Purchase Agreement On May 13, 2022, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with YAII PN, Ltd., a Cayman Island exempt limited partnership, pursuant to which the Investor purchased a full recourse promissory note with an initial principal amount equal to $5,000,000 (the “Promissory Note”) for net cash proceeds of $4,750,000. The Promissory Note included an original issue discount of $250,000, a structuring fee of $10,000, and legal fees of $7,200, which represents the difference between the principal and proceeds received. The original issue discount, along with structuring fees were recorded as a debt discount to be amortized over the term of the Note using the effective interest rate method. The Promissory Note carries an interest rate of 10% per annum. As of September 23, 2022, the Company had fully repaid the principal and interest due in the amounts of $5,000,000 and $165,493, respectively, of which $3,850,000 and $0, respectively, were paid from the proceeds of the Initial Advance (see Note 9 - Prepaid Advance Liability). During the three and nine months ended September 30, 2022, the Company recorded interest expense related to the Promissory note in the amounts of $608,027 and $650,493, respectively, which included $123,027 and $165,493, respectively, of stated interest, a 10% payment premium in the amount of $385,000 and a late payment premium in the amount of $100,000. A summary of notes payable activity during the nine months ended September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Notes Debt ​ ​ ​ Payable ​ Discount ​ Total Balance, January 1, 2022 ​ $ — ​ $ — ​ $ — Proceeds from promissory note ​ 5,000,000 ​ (250,000) ​ 4,750,000 Debt discount ​ — ​ (17,200) ​ (17,200) Repayments in cash ​ ​ (4,850,000) ​ ​ — ​ ​ (4,850,000) Repayments in shares of common stock ​ ​ (150,000) ​ ​ — ​ ​ (150,000) Amortization of debt discount ​ — ​ 258,691 ​ 258,691 Loss on debt extinguishment ​ ​ — ​ ​ 8,509 ​ ​ 8,509 Outstanding, September 30, 2022 ​ $ — ​ $ — ​ $ — ​ ​ Paycheck Protection Program Loan On April 27, 2020, the Company received approximately $155,000 of cash proceeds pursuant to an unsecured loan provided in connection with the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (“CARES Act”). Under the terms of the CARES Act, as amended by the Paycheck Protection Program Flexibility Act of 2020, the Company is eligible to apply for and receive forgiveness for all or a portion of their respective PPP Loans. Such forgiveness will be determined, subject to limitations, based on the use of the loan proceeds for certain permissible purposes as set forth in the PPP, including, but not limited to, payroll costs (as defined under the PPP) and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”) incurred during the 24 weeks subsequent to funding, and on the maintenance of employee and compensation levels, as defined, following the funding of the PPP Loan. The initial term of the loan was two years and was extended to five years with a maturity date of April 27, 2025. The Company applied for forgiveness of the PPP loan, which was approved by the Small Business Administration, and the PPP loan was fully forgiven effective July 18, 2022. The Company has recorded this as a gain on forgiveness of the PPP loan and interest of approximately $155,226 and $3,449, respectively, as other income in the condensed consolidated statement of operations.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2022
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 11 STOCKHOLDERS’ EQUITY Standby Equity Purchase Agreement On May 13, 2022, the Company entered into the SEPA with Yorkville. Pursuant to the SEPA, the Company has the right, but not the obligation, to sell to Yorkville up to an aggregate of $50,000,000 of its shares of common stock, par value $0.0001 per share, at the Company’s request any time during the commitment period commencing on May 13, 2022 and terminating on the first day of the month following the 24-month anniversary of the SEPA. Each sale (an “Advance”) that the Company requests under the SEPA (via an “Advance Notice”) may be for a number of shares of common stock with an aggregate value of up to $5,000,000. Shares are sold under the SEPA at 98.0% of the average of the VWAPs during each of the three As of September 30, 2022, the Company issued Advance Notices to receive $350,000 in exchange for 255,240 shares of common stock pursuant to the SEPA. At any time that there is a balance outstanding under a Prepaid Advance, the Company is not permitted to deliver Advance Notices under the SEPA. See Note 9 – Prepaid Advance Liability, for details related to a supplemental agreement to the SEPA. Common Stock ​ During March 2022, the Company issued an aggregate of 70,143 shares of common stock upon the exercise of warrants pursuant to which the Company received an aggregate of $87,679 of gross proceeds. During April 2022, the Company issued an aggregate of 2,346,525 shares of common stock upon the exercise of warrants pursuant to which the Company received an aggregate of $2,933,156 of gross proceeds. In connection with an inducement offer from the Company, the Company issued new warrants to purchase an aggregate of 2,346,525 shares of common stock at an exercise price of $1.00 per share (the “New Warrants”). The New Warrants expire on December 31, 2025. The value of the New Warrants provided to the exercising warrant holders was deemed to be an offering cost associated with an equity financing to raise capital, pursuant to ASU 2021-04. Because the New Warrants were determined to be classified as equity, the credit to additional paid-in capital associated with the issuance of the New Warrants is offset by the debit to additional paid-in capital related to the offering cost. The warrants had a grant date value of $3,657,763, calculated using the Black Scholes pricing model with the following assumptions used: risk free rate – 2.88%, expected term – 3.69, expected volatility – 100%, expected dividends – 0%. During July 2022, the Company issued an aggregate of 160,782 shares of common stock pursuant to an Advance Notice issued under the SEPA for an aggregate of $250,000 of gross proceeds. During August 2022, the Company issued an aggregate of 94,458 shares of common stock as a partial payment of principal balance due on the Promissory note in the amount of $150,000. On September 29, 2022, the Company issued 221,605 shares of common stock as a partial repayment of the Initial Advance principal amount of $250,000 and interest in the amount of $24,658. During the three and nine months ended September 30, 2022, the Company issued an aggregate of 0 and 12,000 shares of immediately vested common stock with a grant date value of $0 and $53,421, respectively, for legal services. During the three and nine months ended September 30, 2022, the Company issued an aggregate of 30,542 and 66,042 shares, respectively, of common stock upon the exercise of stock options, of which 30,542 and 63,542 shares, respectively, were issued from treasury stock. Treasury Stock ​ The 2018 KULR Technology Group Equity Incentive Plan (the “Plan”) allows for the grant of non-vested stock options, RSUs and RSAs to the Company’s employees pursuant to the terms of the Plan. Under the provision of the Plan, unless otherwise elected, participants fulfill their related income tax withholding obligation by having shares withheld at the time of vesting. The shares withheld are then transferred to the Company’s treasury stock at cost. During the nine months ended September 30, 2022, the Company withheld 194,704 shares valued at $439,728 in connection with the vesting of restricted common stock awards during the period. Pursuant to the exercise of options, the Company transferred 63,542 shares that were held in treasury for an aggregate of $48,382 gross proceeds. As of September 30, 2022, the Company has 131,162 shares held in treasury valued at their cost of $296,222. Warrants A summary of warrants activity during the nine months ended September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Warrants Price Term (Yrs) Value Outstanding, January 1, 2022 2,594,553 ​ $ 1.25 ​ Issued 2,346,525 ​ 1.00 ​ Exercised (2,416,668) ​ (1.25) ​ Expired — ​ — ​ Forfeited — ​ — ​ Outstanding, September 30, 2022 2,524,410 ​ $ 1.02 3.3 ​ $ 662,364 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, September 30, 2022 2,524,410 ​ $ 1.02 3.3 ​ $ 662,364 ​ A summary of outstanding and exercisable warrants as of September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ Warrants Outstanding ​ Warrants Exercisable ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Warrants In Years Warrants $ 1.25 177,885 3.3 177,885 $ 1.00 2,346,525 3.3 2,346,525 ​ ​ 2,524,410 3.3 2,524,410 ​ Stock Options ​ The Company has computed the fair value of stock options granted using the Black-Scholes option pricing model. In applying the Black-Scholes option pricing model, the Company used the following assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Nine Months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Risk free interest rate ​ 2.85% - 4.21% ​ 0.20% - 0.23% ​ 1.18% - 4.21% ​ 0.20% - 0.85% ​ Expected term (years) ​ 3.8 ​ 3.5 ​ 3.5 - 3.9 ​ 2.5 - 3.5 ​ Expected volatility ​ 106 % 109 % 106% - 116% ​ 93% - 109% ​ Expected dividends ​ 0 % 0 % 0 % 0 % ​ For the three and nine months ended September 30, 2022, the weighted average grant date fair value per share of options was $1.08 and $1.31, respectively. For the three and nine months ended September 30, 2021, the stock options had a weighted average grant date value of $1.55 and $0.80 per option share, respectively. A summary of options activity (excluding Market-Based Awards) during the nine months ended September 30, 2022 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Options Price Term (Yrs) Value Outstanding, January 1, 2022 405,216 ​ $ 2.29 ​ Granted 200,000 ​ 1.86 ​ Exercised (66,042) ​ 0.71 ​ Expired — ​ — ​ Forfeited (28,958) ​ 1.49 ​ Outstanding, September 30, 2022 510,216 ​ $ 1.78 3.5 ​ $ 68,501 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, September 30, 2022 184,799 ​ $ 1.37 2.3 ​ $ 65,143 ​ The following table presents information related to stock options (excluding market-based option awards) as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ Options Outstanding ​ Options Exercisable ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Options In Years Options $ 0.66 110,486 1.3 105,070 $ 1.28 ​ 10,000 ​ — ​ — $ 1.35 ​ 10,000 ​ — ​ — $ 1.47 ​ 10,000 ​ — ​ — $ 1.55 ​ 30,000 ​ — ​ — $ 1.59 ​ 40,000 ​ — ​ — $ 1.99 ​ 10,000 ​ 3.7 ​ 4,583 $ 2.05 ​ 50,000 ​ 3.9 ​ 3,958 $ 2.08 10,000 3.6 4,583 $ 2.13 ​ 20,000 ​ 3.9 ​ 7,500 $ 2.25 ​ 10,000 ​ 4.3 ​ 1,250 $ 2.27 ​ 29,730 ​ 3.7 ​ 12,855 $ 2.31 ​ 50,000 ​ — ​ — $ 2.43 ​ 20,000 ​ 4.0 ​ 7,500 $ 2.44 100,000 3.4 37,500 ​ ​ ​ 510,216 ​ 2.3 ​ 184,799 ​ As of September 30, 2022, there was $335,308 of unrecognized stock-based compensation expense related to the above stock options, which will be recognized over the weighted average remaining vesting period of 3.2 years. Restricted Common Stock ​ The following table presents information related to restricted common stock (excluding Market-Based Awards) as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Average ​ ​ ​ ​ Grant Date ​ ​ Shares of Restricted ​ Fair Value ​ Common Stock Per Share Non-vested balance, January 1, 2022 2,590,000 ​ $ 2.52 Granted 150,000 ​ 2.08 Vested (842,500) ​ 2.38 Non-vested shares, September 30, 2022 1,897,500 ​ $ 2.54 ​ As of September 30, 2022, there was $3,963,192 of unrecognized stock-based compensation expense related to restricted stock that will be recognized over the weighted average remaining vesting period of 2.53 years. ​ Market-Based Awards ​ The following table presents information related to market-based awards, that vest upon achieving specified KULR market capitalizations, outstanding as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Grant Date Award Shares Fair Value Restricted stock units 1,500,000 ​ $ 2,911,420 Stock options 1,500,000 ​ ​ 2,579,000 Total 3,000,000 ​ $ 5,490,420 ​ The grant date value for the market-based awards is being amortized over the derived service periods of the awards. As of September 30, 2022, there was $1,605,407 of unrecognized stock-based compensation expense related to market-based awards which will be amortized over the remaining weighted average vesting period of 1.18 years. As of September 30, 2022, none of the market-based awards have vested. See Note 13 – Subsequent Events, Stock-Based Compensation Restructuring regarding cancellation of the market-based awards. ​ Stock-Based Compensation ​ The following table presents information related to stock-based compensation for the three and nine months ended September 30, 2022 and 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Nine Months Ended ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Common stock for services ​ $ — ​ $ 77,040 ​ $ 53,421 ​ $ 345,679 Amortization of restricted common stock ​ 403,812 ​ 440,333 ​ 1,345,171 ​ 1,000,647 Amortization of market-based awards ​ 477,700 ​ 754,207 ​ 1,773,169 ​ 1,374,226 Stock options ​ 23,959 ​ 20,516 ​ 66,377 ​ 45,407 Accrued issuable equity (common stock) ​ ​ 16,840 ​ ​ — ​ ​ (29,360) ​ ​ — Total ​ $ 922,311 ​ $ 1,292,096 ​ $ 3,208,778 ​ $ 2,765,959 ​ During the three and nine months ended September 30, 2022, the Company recognized stock-based compensation expense of $922,311 and $3,208,778, respectively, related to restricted common stock, market-based awards and stock options, of which $916,708 and $3,185,373, respectively are included within selling, general and administrative expenses, and $5,603 and $23,405, respectively are included within research and development expenses in the unaudited condensed consolidated statements of operations. During the three and nine months ended September 30, 2021, the Company recognized stock-based compensation expense of $1,292,096 and $2,765,959, respectively, related to restricted common stock, market-based awards and stock options, of which $1,292,096 and $2,750,769, respectively are included within selling, general and administrative expenses, and $0 and $15,190, respectively are included within research and development expenses on the unaudited condensed consolidated statements of operations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2022
COMMITMENTS AND CONTINGENCIES.
COMMITMENTS AND CONTINGENCIES	NOTE 12 COMMITMENTS AND CONTINGENCIES Sponsorship Agreement On June 15, 2022, the Company amended the Second Sponsorship Agreement (see Note 4 - Prepaid Expenses and Other Current Assets) to extend the term through December 31, 2023. The agreement provides the Company with the right to publicize and highlight the sponsorship and display its name and logo during certain events and use digital marketing and social media platforms throughout the 2023 calendar year. The Company has committed to pay an aggregate of $1,450,000 in sponsorship fees in three installments, which are due in July 2022, January 2023, and April 2023. On July 8, 2022, the Company paid $500,000 which was recorded as a prepaid expense (see Note 4 - Prepaid Expenses and Other Current Assets) and will be amortized over the performance period of January 1, 2023 to December 31, 2023 using the straight-line method. The total remaining commitment amount to be paid for sponsorship agreements is $950,000.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 13 SUBSEQUENT EVENTS Purchase Agreement On October 5, 2022, KULR Technology Group, Inc. (the “Company”) entered into an agreement (the “Purchase Agreement”) with a seller (the “Seller”), pursuant to which the Company purchased all of the assets, including intellectual property, of the Seller (the “Acquired Assets”) for consideration of $3,500,000, of which, $2,000,000 (the “Cash Consideration”) will be paid in cash and the Company will issue shares of common stock worth $1,500,000 (the “Equity Consideration”). The Company will issue the Equity Consideration in four equal installments on the following dates: (i) October 5, 2023, (ii) October 5, 2024, (iii) October 5, 2025, and (iv) October 5, 2026. The Company will pay the Cash Consideration as follows: $1,000,000 on October 6, 2022, $500,000 on April 5, 2023, and $500,000 on October 5, 2023. The Purchase Agreement includes customary representations, warranties and covenants of the Company and the Seller. The Purchase Agreement also contains post-closing indemnification provisions pursuant to which the parties have agreed to indemnify each other against losses resulting from certain events, including breaches of representations and warranties, covenants and certain other matters. The Company is evaluating whether this agreement meets the criteria of a business combination in accordance with the applicable accounting guidance. Supplemental Agreement to the SEPA During October 2022, the Company issued 5,153,664 shares of common stock, at purchase prices per share ranging from $0.99 to $1.84, pursuant to Investor Notices submitted by Yorkville for aggregate proceeds of $5,850,000. The proceeds were applied against the principal and interest due for the initial Prepaid Advance liability in the in the aggregate amounts of $5,750,000 and $100,000, respectively. As of November 14, 2022, the remaining balance on the initial Prepaid Advance liability is $9,000,000. See Note 9 - Prepaid Advance Liability for additional information. Stock-Based Compensation Restructuring On November 1, 2022, the Company terminated the market-based restricted stock unit grant of 1,500,000 shares to vest upon certain market-cap milestones to the Chief Operating Officer (the “COO”) and granted an award of restricted stock units whereby the COO became eligible to receive up to 1,500,000 shares of the Company’s stock which will vest in four equal annual installments beginning on November 1, 2023. On November 1, 2022, the Company terminated the market-based option grant for the purchase of up to 1,500,000 shares to vest upon certain market-cap milestones to the Chief Executive Officer (the “CEO”) and granted an award of restricted stock units whereby the CEO became eligible to receive up to 1,500,000 shares of the Company’s stock which will vest in four equal annual installments beginning on November 1, 2023. Appointment of Chief Technology Officer On March 16, 2022, the Company hired an individual to serve as the Director of Engineering. Effective November 1, 2022, the Company appointed this individual as Chief Technology Officer (the “CTO”) of the Company, upon which the Company issued 100,000 shares of restricted common stock with an aggregate grant date value of $205,000, which shall vest in four equal annual installments beginning November 1, 2023. Director Compensation Effective November 1, 2022, the Board of the Company appointed a Lead Independent Director (“Lead Director”) of the Board, to hold office until the earlier of the expiration of the term of office of the director whom they have replaced, successors are duly elected and qualified, or the earlier of such director’s death, resignation, disqualification, or removal. Furthermore, the Lead Director will receive annual cash compensation equal to $150,000 upon their appointment and the non-Lead Independent Director (“non-Lead Director”) will receive annual cash compensation equal to $95,000. Additionally, all independent Board members will be granted 37,500 shares of common stock of which shares shall vest quarterly in 7,500 share installments with the first installment vesting December 31, 2022.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Liquidity	Liquidity On May 13, 2022, the Company entered into a Standby Equity Purchase Agreement, which gives the Company the right, but not the obligation, to sell up to $50,000,000 of its shares of common stock to the same investor during the commitment period. Further, on September 23, 2022, the Company entered into the Supplemental SEPA, pursuant to which the Company may request advances (“Prepaid Advances”) up to an aggregate of $50,000,000 from Yorkville. Yorkville has the right to receive shares, and may select the timing and delivery of such shares, in an amount up to the balance of the Prepaid Advance in order to pay down the Prepaid Advance liability. During the period ended September 30, 2022, the Company received aggregate gross proceeds of $15,400,000 under the SEPA and the Supplemental SEPA. The Company is not permitted to initiate additional sales of its common stock under the SEPA until the Prepaid Advance liability ($15,539,474 at September 30, 2022) is settled. During October 2022, the Company issued 5,153,664 shares of common stock, at purchase prices per share ranging from $0.99 to $1.84, in satisfaction of the initial Prepaid Advance liability in the aggregate amount of $5,750,000. As of November 14, 2022, the remaining balance on the initial Prepaid Advance liability is $9,000,000. See Note 9 – Prepaid Advance Liability and Note 11 – Stockholders’ Equity for additional information. As of September 30, 2022, the Company had cash of $16,168,863 and working capital of $2,077,848. During the nine months ended September 30, 2022, the Company incurred a net loss of $14,977,825 and used cash in operations of $13,366,007. While the Company anticipates it will continue to incur operating losses and use cash in operating activities for the foreseeable future, the Company believes that its current working capital, combined with the cash availability pursuant to the Standby Equity Purchase Agreement, is sufficient in comparison to its anticipated cash usage for a period of at least twelve months after the filing date of these financial statements.
Use of Estimates	Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these unaudited condensed consolidated financial statements include, but are not limited to, fair value calculations for prepaid advance liability, equity securities, stock-based compensation and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.
Treasury Stock	Treasury Stock The Company records repurchases of its own common stock at cost. Repurchased common stock is presented as a reduction of equity in the Consolidated Balance Sheets. Subsequent reissuances of treasury stock are accounted for on a weighted average cost basis. Differences between the cost of treasury stock and the re-issuance proceeds are charged to additional paid-in capital. Gains on the reissuance of treasury stock are credited to additional paid in capital. Losses resulting from the reissuance of treasury stock are debited to additional paid-in capital to the extent previous net gains from such reissuances are included in additional paid-in capital; any losses in excess of that amount are then charged to retained earnings.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, accounts receivable, revenue and accounts payable. Cash Concentrations A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were uninsured balances of $15,668,863 and $14,363,301 as of September 30, 2022 and December 31, 2021, respectively. Customer and Revenue Concentrations The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company's total accounts receivable, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenues ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ ​ ​ ​ ​ September 30, ​ September 30, ​ As of As of ​ 2022 2021 2022 2021 September 30, 2022 ​ December 31, 2021 Customer A * ​ 88 % * ​ 41 % * ​ 42 % Customer B 67 % * ​ 58 % * ​ 70 % * ​ Customer C 24 % * ​ 23 % * ​ 25 % * ​ Customer D * ​ * ​ * ​ 40 % * ​ * ​ Customer E * ​ * ​ * ​ * ​ * ​ 21 % Customer F * ​ * ​ * ​ * * ​ 34 % Total 91 % 88 % 81 % 81 % 95 % 97 % * Less than 10% ​ There is no assurance the Company will continue to receive significant revenues from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers. Vendor Concentrations Vendor concentrations are as follows for the three and nine months ended September 30, 2022 and 2021, respectively: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, September 30, ​ ​ 2022 2021 2022 2021 ​ Vendor A 65 % * ​ 83 % * ​ Vendor B * ​ 10 % * 42 % Vendor C * ​ * ​ * ​ 47 % ​ 65 % 10 % 83 % 89 % * Less than 10% ​
Inventory	Inventory Inventory is comprised of carbon fiber velvet (“CFV”) thermal interface solutions and internal short circuit batteries, which are available for sale. Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. The cost of inventory that is sold to third parties is included within cost of sales and the cost of inventory that is given as samples is included within operating expenses. The Company periodically reviews for slow-moving, excess or obsolete inventories. Products that are determined to be obsolete, if any, are written down to net realizable value. Inventory at September 30, 2022 and December 31, 2021 was consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2022 ​ 2021 Raw materials ​ $ 61,388 ​ $ — Work-in-process ​ ​ 70,195 ​ ​ 5,500 Finished goods ​ 210,591 ​ 185,811 Total inventory ​ $ 342,174 ​ $ 191,311 ​
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer; ● Step 2: Identify the performance obligations in the contract; ● Step 3: Determine the transaction price; ● Step 4: Allocate the transaction price to the performance obligations in the contract; and ● Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: ● Product sales – Revenue is recognized at the point in time the customer obtains control of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. ● Contract services – Revenue is recognized at the point in time that the Company satisfies its performance obligation under the contract, which is generally at the time the services are fulfilled and/or accepted by the customer. The following table summarizes the Company’s revenue recognized in its consolidated statements of operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Product sales ​ $ 1,369,857 ​ $ 600,921 ​ $ 2,100,120 ​ $ 1,356,530 Contract services ​ 23,328 ​ — ​ 81,110 ​ 290,540 Total revenue ​ $ 1,393,185 ​ $ 600,921 ​ $ 2,181,230 ​ $ 1,647,070 ​ As of September 30, 2022 and December 31, 2021, respectively, the Company had $20,000 and $132,303 of deferred revenue, respectively, from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract, or the customers have not officially accepted the goods or services provided under the contract. During the three and nine months ended September 30, 2022, the Company recognized $0 and $112,303, respectively, that was included in deferred revenue in a previous period. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods. As of September 30, 2022 and December 31, 2021, the Company had $8,535 and $84,324, respectively, of deferred labor costs, which is included in prepaid expenses and other current assets in the Company’s unaudited condensed consolidated balance sheets. Deferred labor costs represent costs to fulfill the Company’s contract service revenue. The Company will recognize the deferred labor costs as cost of revenues at the point in time that the Company satisfies its performance obligation under the respective contract, which is generally at the time the services are fulfilled and/or accepted by the customer.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. ​ The following table presents the computation of basic and diluted net loss per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ ​ 2022 2021 ​ 2022 2021 Numerator: ​ ​ ​ ​ Net income (loss) ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (7,837,798) Deemed dividend to Series D preferred stockholders ​ ​ — ​ ​ — ​ ​ — ​ ​ (2,624,326) Net loss attributable to common stockholders ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (10,462,124) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted-average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 107,402,727 ​ 101,548,848 ​ 106,271,765 ​ 95,641,862 Less:Treasury shares purchased ​ (131,494) ​ — ​ (122,944) ​ — Less:Unvested restricted shares ​ (1,948,370) ​ (2,530,217) ​ (2,106,923) ​ ​ (1,825,659) Add:Accrued issuable equity ​ ​ 249,957 ​ ​ — ​ ​ 181,480 ​ ​ — Denominator for basic and diluted net loss per share ​ ​ 105,572,820 ​ ​ 99,018,630 ​ ​ 104,223,378 ​ ​ 93,816,203 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.05) ​ $ (0.03) ​ $ (0.14) ​ $ (0.11) ​ ​ The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ 2022 2021 Unvested restricted stock ​ 1,897,500 ​ 2,615,000 Unvested market -based equity awards ​ 3,000,000 ​ 3,000,000 Options 510,216 590,000 Warrants ​ 2,524,410 ​ 5,202,878 Total 7,932,126 11,407,878
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2020, the FASB issued ASU 2020-10 “Codification Improvements”, which improves consistency by amending the Codification to include all disclosure guidance in the appropriate disclosure sections and clarifies application of various provisions in the Codification by amending and adding new headings, cross referencing to other guidance, and refining or correcting terminology. The guidance is effective for the Company beginning in the first quarter of fiscal year 2022 with early adoption permitted. The Company adopted ASU 2020-10 effective January 1, 2022 and its adoption did not have a material impact on its condensed consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 and its adoption did not have a material impact on its condensed consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of concentrations of credit risk	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenues ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ ​ ​ ​ ​ September 30, ​ September 30, ​ As of As of ​ 2022 2021 2022 2021 September 30, 2022 ​ December 31, 2021 Customer A * ​ 88 % * ​ 41 % * ​ 42 % Customer B 67 % * ​ 58 % * ​ 70 % * ​ Customer C 24 % * ​ 23 % * ​ 25 % * ​ Customer D * ​ * ​ * ​ 40 % * ​ * ​ Customer E * ​ * ​ * ​ * ​ * ​ 21 % Customer F * ​ * ​ * ​ * * ​ 34 % Total 91 % 88 % 81 % 81 % 95 % 97 % * Less than 10% ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, September 30, ​ ​ 2022 2021 2022 2021 ​ Vendor A 65 % * ​ 83 % * ​ Vendor B * ​ 10 % * 42 % Vendor C * ​ * ​ * ​ 47 % ​ 65 % 10 % 83 % 89 % * Less than 10%
Schedule of inventory	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2022 ​ 2021 Raw materials ​ $ 61,388 ​ $ — Work-in-process ​ ​ 70,195 ​ ​ 5,500 Finished goods ​ 210,591 ​ 185,811 Total inventory ​ $ 342,174 ​ $ 191,311
Schedule of revenue recognized	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Product sales ​ $ 1,369,857 ​ $ 600,921 ​ $ 2,100,120 ​ $ 1,356,530 Contract services ​ 23,328 ​ — ​ 81,110 ​ 290,540 Total revenue ​ $ 1,393,185 ​ $ 600,921 ​ $ 2,181,230 ​ $ 1,647,070
Schedule of of basic and diluted net loss per common share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Nine Months Ended ​ ​ September 30, ​ September 30, ​ ​ 2022 2021 ​ 2022 2021 Numerator: ​ ​ ​ ​ Net income (loss) ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (7,837,798) Deemed dividend to Series D preferred stockholders ​ ​ — ​ ​ — ​ ​ — ​ ​ (2,624,326) Net loss attributable to common stockholders ​ $ (5,586,585) ​ $ (3,095,932) ​ $ (14,977,825) ​ $ (10,462,124) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted-average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 107,402,727 ​ 101,548,848 ​ 106,271,765 ​ 95,641,862 Less:Treasury shares purchased ​ (131,494) ​ — ​ (122,944) ​ — Less:Unvested restricted shares ​ (1,948,370) ​ (2,530,217) ​ (2,106,923) ​ ​ (1,825,659) Add:Accrued issuable equity ​ ​ 249,957 ​ ​ — ​ ​ 181,480 ​ ​ — Denominator for basic and diluted net loss per share ​ ​ 105,572,820 ​ ​ 99,018,630 ​ ​ 104,223,378 ​ ​ 93,816,203 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.05) ​ $ (0.03) ​ $ (0.14) ​ $ (0.11)
Schedule of shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive	​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ 2022 2021 Unvested restricted stock ​ 1,897,500 ​ 2,615,000 Unvested market -based equity awards ​ 3,000,000 ​ 3,000,000 Options 510,216 590,000 Warrants ​ 2,524,410 ​ 5,202,878 Total 7,932,126 11,407,878

PREPAID EXPENSES AND OTHER CU_2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	9 Months Ended
	Sep. 30, 2022
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Schedule of prepaid expenses and other current assets	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ 2022 2021 Marketing ​ $ 650,766 ​ $ 10,231 Vendor receivables ​ ​ 100,000 ​ ​ — Other ​ ​ 98,535 ​ ​ 31,074 Professional fees ​ ​ 83,711 ​ ​ 65,118 Subscriptions ​ ​ 47,217 ​ ​ — Insurance ​ ​ 42,069 ​ ​ 69,925 Deferred labor costs ​ ​ 8,535 ​ ​ 84,324 Total prepaid expenses and other current assets ​ $ 1,030,833 ​ $ 260,672

ACCRUED EXPENSES AND OTHER CU_2

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2022
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Schedule of accrued expenses and other current liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Legal and professional fees ​ $ 1,088,561 ​ $ 418,154 Payroll and vacation ​ ​ 435,246 ​ ​ 302,101 Research and development ​ ​ 169,497 ​ ​ 146,158 Other ​ ​ 105,803 ​ ​ 84,824 Board compensation ​ 24,041 ​ 45,680 Accrued cost of sales ​ ​ — ​ ​ 128,500 Marketing and advertising fees ​ ​ — ​ ​ 37,810 Total accrued expenses and other current liabilities ​ $ 1,823,148 ​ $ 1,163,227

ACCRUED ISSUABLE EQUITY (Tables

ACCRUED ISSUABLE EQUITY (Tables)	9 Months Ended
	Sep. 30, 2022
ACCRUED ISSUABLE EQUITY
Schedule of accrued issuable equity	​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended ​ September 30, 2022 Beginning Balance ​ $ 290,721 Additions ​ ​ 62,640 Cancelled accrued issuable equity obligations ​ ​ (92,000) Mark-to market ​ ​ (123,121) Ending Balance ​ $ 138,240

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2022
LEASES
Schedule of maturities of lease liabilities	Maturities of lease liabilities as of September 30, 2022 were as follows: ​ ​ ​ ​ ​ Maturity Date ​ ​ October 1 through December 31, 2022 ​ $ 57,499 2023 ​ 234,694 2024 ​ 99,187 Total lease payments ​ 391,380 Less: Imputed interest ​ (16,740) Present value of lease liabilities ​ 374,640 Less: current portion ​ (218,875) Lease liabilities, non-current portion ​ $ 155,765
Schedule of supplemental cash flow information related to the lease	​ ​ ​ ​ ​ ​ For the Nine Months Ended ​ September 30, 2022 Cash paid for amounts included in the measurement of lease liabilities ​ ​ ​ Operating cash flows from operating lease ​ $ 143,861

PREPAID ADVANCE LIABILITY (Tabl

PREPAID ADVANCE LIABILITY (Tables)	9 Months Ended
	Sep. 30, 2022
PREPAID ADVANCE LIABILITY
Summary of Prepaid Advance liability	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Amount of Less: Prepaid Advance ​ ​ Prepaid Advance ​ Debt ​ Liability, net of ​ ​ Liability ​ Discount ​ discount Balance, January 1, 2022 ​ $ — ​ $ — ​ $ — Proceeds from prepaid advance ​ 15,000,000 ​ — ​ 15,000,000 Original issue discount ​ 789,474 ​ (789,474) ​ — Legal fees ​ ​ — ​ ​ (85,000) ​ ​ (85,000) Repayments in cash ​ ​ — ​ ​ — ​ ​ — Repayments in shares of common stock ​ (250,000) ​ — ​ (250,000) Amortization of debt discount ​ ​ — ​ ​ 16,934 ​ ​ 16,934 Outstanding, September 30, 2022 ​ $ 15,539,474 ​ $ (857,540) ​ $ 14,681,934

NOTES AND LOANS PAYABLE (Tables

NOTES AND LOANS PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2022
NOTES AND LOANS PAYABLE
Summary of notes payable activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Notes Debt ​ ​ ​ Payable ​ Discount ​ Total Balance, January 1, 2022 ​ $ — ​ $ — ​ $ — Proceeds from promissory note ​ 5,000,000 ​ (250,000) ​ 4,750,000 Debt discount ​ — ​ (17,200) ​ (17,200) Repayments in cash ​ ​ (4,850,000) ​ ​ — ​ ​ (4,850,000) Repayments in shares of common stock ​ ​ (150,000) ​ ​ — ​ ​ (150,000) Amortization of debt discount ​ — ​ 258,691 ​ 258,691 Loss on debt extinguishment ​ ​ — ​ ​ 8,509 ​ ​ 8,509 Outstanding, September 30, 2022 ​ $ — ​ $ — ​ $ —

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	9 Months Ended
	Sep. 30, 2022
STOCKHOLDERS' EQUITY
Schedule of warrants activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Warrants Price Term (Yrs) Value Outstanding, January 1, 2022 2,594,553 ​ $ 1.25 ​ Issued 2,346,525 ​ 1.00 ​ Exercised (2,416,668) ​ (1.25) ​ Expired — ​ — ​ Forfeited — ​ — ​ Outstanding, September 30, 2022 2,524,410 ​ $ 1.02 3.3 ​ $ 662,364 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, September 30, 2022 2,524,410 ​ $ 1.02 3.3 ​ $ 662,364
Schedule of outstanding and exercisable warrants	​ ​ ​ ​ ​ ​ ​ ​ ​ Warrants Outstanding ​ Warrants Exercisable ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Warrants In Years Warrants $ 1.25 177,885 3.3 177,885 $ 1.00 2,346,525 3.3 2,346,525 ​ ​ 2,524,410 3.3 2,524,410
Schedule of stock option activity outstanding and exercisable	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Options Price Term (Yrs) Value Outstanding, January 1, 2022 405,216 ​ $ 2.29 ​ Granted 200,000 ​ 1.86 ​ Exercised (66,042) ​ 0.71 ​ Expired — ​ — ​ Forfeited (28,958) ​ 1.49 ​ Outstanding, September 30, 2022 510,216 ​ $ 1.78 3.5 ​ $ 68,501 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, September 30, 2022 184,799 ​ $ 1.37 2.3 ​ $ 65,143 ​ ​ ​ ​ ​ ​ ​ ​ ​ Options Outstanding ​ Options Exercisable ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Options In Years Options $ 0.66 110,486 1.3 105,070 $ 1.28 ​ 10,000 ​ — ​ — $ 1.35 ​ 10,000 ​ — ​ — $ 1.47 ​ 10,000 ​ — ​ — $ 1.55 ​ 30,000 ​ — ​ — $ 1.59 ​ 40,000 ​ — ​ — $ 1.99 ​ 10,000 ​ 3.7 ​ 4,583 $ 2.05 ​ 50,000 ​ 3.9 ​ 3,958 $ 2.08 10,000 3.6 4,583 $ 2.13 ​ 20,000 ​ 3.9 ​ 7,500 $ 2.25 ​ 10,000 ​ 4.3 ​ 1,250 $ 2.27 ​ 29,730 ​ 3.7 ​ 12,855 $ 2.31 ​ 50,000 ​ — ​ — $ 2.43 ​ 20,000 ​ 4.0 ​ 7,500 $ 2.44 100,000 3.4 37,500 ​ ​ ​ 510,216 ​ 2.3 ​ 184,799
Schedule of restricted common stock and market-based awards	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Average ​ ​ ​ ​ Grant Date ​ ​ Shares of Restricted ​ Fair Value ​ Common Stock Per Share Non-vested balance, January 1, 2022 2,590,000 ​ $ 2.52 Granted 150,000 ​ 2.08 Vested (842,500) ​ 2.38 Non-vested shares, September 30, 2022 1,897,500 ​ $ 2.54
Schedule of Information relating to stock based compensation	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Nine Months Ended ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Common stock for services ​ $ — ​ $ 77,040 ​ $ 53,421 ​ $ 345,679 Amortization of restricted common stock ​ 403,812 ​ 440,333 ​ 1,345,171 ​ 1,000,647 Amortization of market-based awards ​ 477,700 ​ 754,207 ​ 1,773,169 ​ 1,374,226 Stock options ​ 23,959 ​ 20,516 ​ 66,377 ​ 45,407 Accrued issuable equity (common stock) ​ ​ 16,840 ​ ​ — ​ ​ (29,360) ​ ​ — Total ​ $ 922,311 ​ $ 1,292,096 ​ $ 3,208,778 ​ $ 2,765,959
Options
STOCKHOLDERS' EQUITY
Schedule of assumptions for computing fair value of stock options granted using the Black-Scholes option pricing model	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Nine Months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Risk free interest rate ​ 2.85% - 4.21% ​ 0.20% - 0.23% ​ 1.18% - 4.21% ​ 0.20% - 0.85% ​ Expected term (years) ​ 3.8 ​ 3.5 ​ 3.5 - 3.9 ​ 2.5 - 3.5 ​ Expected volatility ​ 106 % 109 % 106% - 116% ​ 93% - 109% ​ Expected dividends ​ 0 % 0 % 0 % 0 %
Amortization of market-based awards
STOCKHOLDERS' EQUITY
Schedule of restricted common stock and market-based awards	​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Grant Date Award Shares Fair Value Restricted stock units 1,500,000 ​ $ 2,911,420 Stock options 1,500,000 ​ ​ 2,579,000 Total 3,000,000 ​ $ 5,490,420

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer, Revenue and Vendor Concentrations (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage	91%	88%	81%	81%
Revenues | Customer A | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage		88%		41%
Revenues | Customer B | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage	67%		58%
Revenues | Customer C | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage	24%		23%
Revenues | Customer D | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage				40%
Accounts Receivable | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage			95%		97%
Accounts Receivable | Customer A | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage					42%
Accounts Receivable | Customer B | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage			70%
Accounts Receivable | Customer C | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage			25%
Accounts Receivable | Customer E | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage					21%
Accounts Receivable | Customer F | Credit Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage					34%
Accounts Payable | Supplier Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage	65%	10%	83%	89%
Accounts Payable | Supplier Concentration Risk | Vendor A
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage	65%		83%
Accounts Payable | Supplier Concentration Risk | Vendor B
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage		10%		42%
Accounts Payable | Supplier Concentration Risk | Vendor C
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration Risk, Percentage				47%

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Raw materials	$ 61,388
Work-in-process	70,195	$ 5,500
Finished goods	210,591	185,811
Total inventory	$ 342,174	$ 191,311

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Company's revenue recognized in its consolidated statements of operations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	$ 1,393,185	$ 600,921	$ 2,181,230	$ 1,647,070
Product sales
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	1,369,857	$ 600,921	2,100,120	1,356,530
Contract services
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	$ 23,328		$ 81,110	$ 290,540

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of basic and diluted net loss per common share (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income (loss)	$ (5,586,585)	$ (5,254,685)	$ (4,136,555)	$ (3,095,932)	$ (3,027,143)	$ (1,714,723)	$ (14,977,825)	$ (7,837,798)
Deemed dividend to Series D preferred stockholders								(2,624,326)
Net Loss Attributable to Common Stockholders	$ (5,586,585)			$ (3,095,932)			$ (14,977,825)	$ (10,462,124)
Denominator (weighted-average quantities):
Common shares issued	107,402,727			101,548,848			106,271,765	95,641,862
Less:Treasury shares purchased	(131,494)						(122,944)
Less:Unvested restricted shares	(1,948,370)			(2,530,217)			(2,106,923)	(1,825,659)
Add:Accrued issuable equity	249,957						181,480
Denominator for basic net loss per share	105,572,820			99,018,630			104,223,378	93,816,203
Denominator for diluted net loss per share	105,572,820			99,018,630			104,223,378	93,816,203
Basic net loss per common share (In dollars per share)	$ (0.05)			$ (0.03)			$ (0.14)	$ (0.11)
Diluted net loss per common share (In dollars per share)	$ (0.05)			$ (0.03)			$ (0.14)	$ (0.11)

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	7,932,126	11,407,878
Unvested restricted stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	1,897,500	2,615,000
Unvested market -based equity awards
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	3,000,000	3,000,000
Options
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	510,216	590,000
Warrants
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	2,524,410	5,202,878

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended						9 Months Ended
	Oct. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Nov. 14, 2022	Sep. 23, 2022	May 13, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Prepaid advance liability		$ 15,539,474						$ 15,539,474
Amount of prepaid advance liability satisfied by issuance of shares		274,658
Remaining balance on initial Prepaid Advance liability		14,681,934						14,681,934					$ 0
Cash		16,168,863						16,168,863					14,863,301
Working capital		2,077,848						2,077,848
Net loss		(5,586,585)	$ (5,254,685)	$ (4,136,555)	$ (3,095,932)	$ (3,027,143)	$ (1,714,723)	(14,977,825)	$ (7,837,798)
Cash in operations								13,366,007	5,394,936
Cash, FDIC insured amount		250,000						250,000
Uninsured cash		15,668,863						15,668,863					14,363,301
Deferred revenue		20,000						20,000					132,303
Revenue recognized from performance obligations		0			$ 0			112,303	$ 0
Deferred labor costs		$ 8,535						8,535					$ 84,324
SEPA
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Value of shares to be issued											$ 50,000,000	$ 50,000,000
Aggregate gross proceeds								$ 15,400,000
Supplemental Agreement to the SEPA | Subsequent event
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares issued during the period (in shares)	5,153,664
Amount of prepaid advance liability satisfied by issuance of shares	$ 5,750,000
Remaining balance on initial Prepaid Advance liability										$ 9,000,000
Supplemental Agreement to the SEPA | Subsequent event | Minimum
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Purchase price per share	$ 0.99
Supplemental Agreement to the SEPA | Subsequent event | Maximum
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Purchase price per share	$ 1.84

INVENTORY DEPOSITS (Details)

INVENTORY DEPOSITS (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
INVENTORY DEPOSITS
Inventory deposits	$ 1,031,150	$ 309,688

PREPAID EXPENSES AND OTHER CU_3

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Marketing	$ 650,766	$ 10,231
Vendor receivables	100,000
Other	98,535	31,074
Professional fees	83,711	65,118
Subscriptions	47,217
Insurance	42,069	69,925
Deferred labor costs	8,535	84,324
Total prepaid expenses and other current assets	1,030,833	$ 260,672
Prepayments of contracts	2,150,000
Unamortized prepaid marketing costs	$ 575,000

EQUIPMENT DEPOSITS (Details)

EQUIPMENT DEPOSITS (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
EQUIPMENT DEPOSITS
Equipment deposits	$ 4,465,937	$ 2,153,950

ACCRUED EXPENSES AND OTHER CU_3

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Legal and professional fees	$ 1,088,561	$ 418,154
Payroll and vacation	435,246	302,101
Research and development	169,497	146,158
Other	105,803	84,824
Board compensation	24,041	45,680
Accrued cost of sales		128,500
Marketing and advertising fees		37,810
Total accrued expenses and other current liabilities	$ 1,823,148	$ 1,163,227

ACCRUED ISSUABLE EQUITY (Detail

ACCRUED ISSUABLE EQUITY (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
ACCRUED ISSUABLE EQUITY
Beginning Balance	$ 290,721
Additions	62,640
Cancelled accrued issuable equity obligations	(92,000)
Mark-to market	(123,121)
Ending Balance	$ 138,240

ACCRUED ISSUABLE EQUITY - Addit

ACCRUED ISSUABLE EQUITY - Additional information (Details)	9 Months Ended
	Sep. 30, 2022 USD ($) shares
ACCRUED ISSUABLE EQUITY
Value of services	$ 62,640
Shares issued in exchange for certain services, aggregate shares | shares	33,333
Shares issued in exchange for services, aggregate fair value	$ 92,000
Gains (losses) related to the change in fair value	123,121
Fair value of unissued share	$ 138,240

LEASES - Maturity (Details)

LEASES - Maturity (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
LEASES
October 1 through December 31, 2022	$ 57,499
2023	234,694
2024	99,187
Total lease payments	391,380
Less: Imputed interest	(16,740)
Present value of lease liabilities	374,640
Less: current portion	(218,875)	$ (262,379)
Lease liabilities, non-current portion	$ 155,765	$ 407,898

LEASES - Supplemental cash flow

LEASES - Supplemental cash flow information related to the lease (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating lease	$ 143,861

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
LEASES
Operating lease expense	$ 57,522	$ 89,305	$ 188,854	$ 144,765
Security deposit	$ 50,213		$ 50,213

PREPAID ADVANCE LIABILITY (Deta

PREPAID ADVANCE LIABILITY (Details) - USD ($)			9 Months Ended
	Sep. 29, 2022	Sep. 23, 2022	Sep. 30, 2022	Sep. 30, 2021
PREPAID ADVANCE LIABILITY
Repayments of notes payable			$ 1,000,000	$ 2,450,000
Yorkville
PREPAID ADVANCE LIABILITY
Prepaid advance		$ 15,000,000
Maximum prepaid advance		$ 50,000,000
Prepaid Advance, maturity period after the date of closing of advance		12 months
Percentage of interest rate per annum		10%
Percentage of interest rate upon default per annum		15%
Percentage of VWAP of common stock		135%
Percentage of lowest VWAP of common stock		95%
Period for calculating VWAP		3 days
Prepayment notice period		10 days
VWAP per share, minimum value		$ 0.75
Percentage of payment premium		5%
Monthly repayment amount		$ 3,000,000
Initial advance		15,000,000
Original issue discount		789,474
Repayments of notes payable		$ 3,850,000
Number of shares issued (in shares)	221,605
Initial Advance principal amount	$ 250,000
Interest expense	$ 24,658

PREPAID ADVANCE LIABILITY - Pre

PREPAID ADVANCE LIABILITY - Prepaid Advance liability (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 23, 2022
PREPAID ADVANCE LIABILITY
Outstanding, September 30, 2022	$ 15,539,474
Yorkville
PREPAID ADVANCE LIABILITY
Balance, January 1, 2022	0
Proceeds from prepaid advance	15,000,000
Original issue discount		$ 789,474
Legal fees	(85,000)
Repayments in shares of common stock	(250,000)
Amortization of debt discount	16,934
Outstanding, September 30, 2022	14,681,934
Yorkville | Gross Amount of Prepaid Advance Liability
PREPAID ADVANCE LIABILITY
Balance, January 1, 2022	0
Proceeds from prepaid advance	15,000,000
Original issue discount	789,474
Repayments in shares of common stock	(250,000)
Outstanding, September 30, 2022	15,539,474
Yorkville | Less: Debt Discount
PREPAID ADVANCE LIABILITY
Balance, January 1, 2022	0
Original issue discount	(789,474)
Legal fees	(85,000)
Amortization of debt discount	16,934
Outstanding, September 30, 2022	$ (857,540)

NOTES AND LOANS PAYABLE (Detail

NOTES AND LOANS PAYABLE (Details) - USD ($)				3 Months Ended	9 Months Ended
		Sep. 23, 2022	May 13, 2022	Sep. 30, 2022	Sep. 30, 2022
NOTES AND LOANS PAYABLE
Net cash proceeds	[1]				$ 4,750,000
Promissory Note
NOTES AND LOANS PAYABLE
Initial principal amount				$ 5,000,000	5,000,000
Original issue discount					250,000
Promissory Note | Note Purchase Agreement
NOTES AND LOANS PAYABLE
Initial principal amount			$ 5,000,000
Net cash proceeds			4,750,000
Original issue discount			250,000
Structuring fee			10,000
Legal fees in connection with note purchase agreement			$ 7,200
Interest rate per annum (in percentage)			10%
Repayment of principal amount of debt		$ 5,000,000
Repayment of interest amount		165,493
Repayment of debt from proceeds of advance liability		3,850,000
Repayment of Interest on debt from proceeds of advance liability		$ 0
Interest expense				608,027	650,493
Interest expense stated interest				$ 123,027	$ 165,493
Premium percentage				10%	10%
Premium payment				$ 385,000	$ 385,000
Late premium payment				$ 100,000	$ 100,000
[1] Note payable face of $5,000,000 , less $250,000 original issue discount.

NOTES AND LOANS PAYABLE - Summa

NOTES AND LOANS PAYABLE - Summary of notes payable activity (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Debt Discount
Loss on debt extinguishment	$ (8,508)	$ (8,508)
Total
Loss on debt extinguishment	(8,508)	(8,508)
Promissory Note
Notes Payable
Beginning balance		0
Proceeds from promissory note		5,000,000
Repayments in cash		(4,850,000)
Repayments in shares of common stock		(150,000)
Ending balance	0	0
Debt Discount
Beginning balance		0
Proceeds from promissory note		(250,000)
Debt discount		(17,200)
Amortization of debt discount		258,691
Loss on debt extinguishment		8,509
Ending balance	0	0
Total
Beginning balance		0
Proceeds from promissory note		4,750,000
Debt discount		(17,200)
Repayments in cash		(4,850,000)
Repayments in shares of common stock		(150,000)
Amortization of debt discount		258,691
Loss on debt extinguishment		8,509
Ending balance	$ 0	$ 0

NOTES AND LOANS PAYABLE - Paych

NOTES AND LOANS PAYABLE - Paycheck Protection Program Loan (Details) - Payment Protection Loans - USD ($)		9 Months Ended
	Apr. 27, 2020	Sep. 30, 2022
NOTES AND LOANS PAYABLE
Cash proceeds from unsecured loan	$ 155,000
Loan maturity term		2 years
Extended maturity term		5 years
Gain on forgiveness of PPP loan		$ 155,226
Gain on forgiveness of loan interest		$ 3,449

STOCKHOLDERS' EQUITY - Summary

STOCKHOLDERS' EQUITY - Summary of warrants activity (Details) - Warrants	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares
STOCKHOLDERS' EQUITY
Number of Warrants, Outstanding at the beginning | shares	2,594,553
Number of Warrants, Issued | shares	2,346,525
Number of warrants, Exercised | shares	(2,416,668)
Number of Warrants, Outstanding at the end | shares	2,524,410
Number of Warrants, Exercisable at the end | shares	2,524,410
Weighted Average Exercise Price, Outstanding, Beginning (in dollars per share) | $ / shares	$ 1.25
Weighted Average Exercise Price, Issued (in dollars per share) | $ / shares	1
Weighted Average Exercise Price, Exercised (in dollars per share) | $ / shares	(1.25)
Weighted Average Exercise Price, Outstanding, Ending (in dollars per share) | $ / shares	1.02
Weighted Average Exercise Price, Exercisable at the end (in dollars per share) | $ / shares	$ 1.02
Weighted Average Remaining Term, Outstanding at the end (in years)	3 years 3 months 18 days
Weighted Average Remaining Term, Exercisable at the end (in years)	3 years 3 months 18 days
Intrinsic Value, Outstanding at the end (in dollars) | $	$ 662,364
Intrinsic Value, Exercisable at the end (in dollars) | $	$ 662,364

STOCKHOLDERS' EQUITY - Outstand

STOCKHOLDERS' EQUITY - Outstanding and exercisable warrants (Details) - Warrants	Sep. 30, 2022 $ / shares shares
STOCKHOLDERS' EQUITY
Number of Warrants Outstanding	2,524,410
Exercisable, Weighted Average Remaining Life (in years)	3 years 3 months 18 days
Exercisable, Number of Warrants	2,524,410
Exercise price, 1.25
STOCKHOLDERS' EQUITY
Exercise Price of Warrants Outstanding (in dollars per share) | $ / shares	$ 1.25
Number of Warrants Outstanding	177,885
Exercisable, Weighted Average Remaining Life (in years)	3 years 3 months 18 days
Exercisable, Number of Warrants	177,885
Exercise price, 1.00
STOCKHOLDERS' EQUITY
Exercise Price of Warrants Outstanding (in dollars per share) | $ / shares	$ 1
Number of Warrants Outstanding	2,346,525
Exercisable, Weighted Average Remaining Life (in years)	3 years 3 months 18 days
Exercisable, Number of Warrants	2,346,525

STOCKHOLDERS' EQUITY - Assumpti

STOCKHOLDERS' EQUITY - Assumptions used for computing the fair value of stock options granted using the Black-Scholes option pricing model (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
STOCKHOLDERS' EQUITY
Expected term (years)	3 years 9 months 18 days	3 years 6 months
Expected volatility	106%	109%
Expected dividends	0%	0%	0%	0%
Minimum
STOCKHOLDERS' EQUITY
Risk free interest rate	2.85%	0.20%	1.18%	0.20%
Expected term (years)			3 years 6 months	2 years 6 months
Expected volatility			106%	93%
Maximum
STOCKHOLDERS' EQUITY
Risk free interest rate	4.21%	0.23%	4.21%	0.85%
Expected term (years)			3 years 10 months 24 days	3 years 6 months
Expected volatility			116%	109%

STOCKHOLDERS' EQUITY - Summar_2

STOCKHOLDERS' EQUITY - Summary of options activity (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
STOCKHOLDERS' EQUITY
Number of Options, Outstanding		405,216
Number of Options, Granted		200,000
Number of Options, Exercised	(30,542)	(66,042)
Number of Options, Forfeited		(28,958)
Number of Options, Outstanding	510,216	510,216
Number of Options, Exercisable	184,799	184,799
Weighted Average Exercise Price, Outstanding		$ 2.29
Weighted Average Exercise Price, Granted		1.86
Weighted Average Exercise Price, Exercised		0.71
Weighted Average Exercise Price, Forfeited		1.49
Weighted Average Exercise Price Outstanding	$ 1.78	1.78
Weighted Average Exercise Price Exercisable	$ 1.37	$ 1.37
Weighted Average Remaining Term, Outstanding		3 years 6 months
Weighted Average Remaining Term, Exercisable		2 years 3 months 18 days
Number of Options Intrinsic Value, Outstanding	$ 68,501	$ 68,501
Number of Options Intrinsic Value, Exercisable	$ 65,143	$ 65,143

STOCKHOLDERS' EQUITY - Stock op

STOCKHOLDERS' EQUITY - Stock options (Details) - $ / shares	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.37
Options Outstanding, Number of Options	510,216	405,216
Options Exercisable, Weighted Average Remaining Life	2 years 3 months 18 days
Options Exercisable Number of Options	184,799
0.66 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 0.66
Options Outstanding, Number of Options	110,486
Options Exercisable, Weighted Average Remaining Life	1 year 3 months 18 days
Options Exercisable Number of Options	105,070
1.28 Exercise price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.28
Options Outstanding, Number of Options	10,000
1.35 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.35
Options Outstanding, Number of Options	10,000
1.47 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.47
Options Outstanding, Number of Options	10,000
1.55 Exercise price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.55
Options Outstanding, Number of Options	30,000
1.59 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.59
Options Outstanding, Number of Options	40,000
1.99 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 1.99
Options Outstanding, Number of Options	10,000
Options Exercisable, Weighted Average Remaining Life	3 years 8 months 12 days
Options Exercisable Number of Options	4,583
2.05 exercise price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.05
Options Outstanding, Number of Options	50,000
Options Exercisable, Weighted Average Remaining Life	3 years 10 months 24 days
Options Exercisable Number of Options	3,958
2.08 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.08
Options Outstanding, Number of Options	10,000
Options Exercisable, Weighted Average Remaining Life	3 years 7 months 6 days
Options Exercisable Number of Options	4,583
2.13 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.13
Options Outstanding, Number of Options	20,000
Options Exercisable, Weighted Average Remaining Life	3 years 10 months 24 days
Options Exercisable Number of Options	7,500
2.25 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.25
Options Outstanding, Number of Options	10,000
Options Exercisable, Weighted Average Remaining Life	4 years 3 months 18 days
Options Exercisable Number of Options	1,250
2.27 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.27
Options Outstanding, Number of Options	29,730
Options Exercisable, Weighted Average Remaining Life	3 years 8 months 12 days
Options Exercisable Number of Options	12,855
2.31 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.31
Options Outstanding, Number of Options	50,000
2.43 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.43
Options Outstanding, Number of Options	20,000
Options Exercisable, Weighted Average Remaining Life	4 years
Options Exercisable Number of Options	7,500
2.44 Exercise Price
STOCKHOLDERS' EQUITY
Options Outstanding, Exercise Price	$ 2.44
Options Outstanding, Number of Options	100,000
Options Exercisable, Weighted Average Remaining Life	3 years 4 months 24 days
Options Exercisable Number of Options	37,500

STOCKHOLDERS' EQUITY - Restrict

STOCKHOLDERS' EQUITY - Restricted Common Stock (Details) - Restricted common stock	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Shares of Restricted Common Stock
Non-vested balance, January 1, 2022 | shares	2,590,000
Granted | shares	150,000
Vested | shares	(842,500)
Non-vested shares, September 30, 2022 | shares	1,897,500
Weighted Average Grant Date Fair Value Per Share
Non-vested balance, January 1, 2022 (in dollars per share) | $ / shares	$ 2.52
Granted (in dollars per share) | $ / shares	2.08
Vested (in dollars per share) | $ / shares	2.38
Non-vested shares, September 30, 2022 (in dollars per share) | $ / shares	$ 2.54

STOCKHOLDERS' EQUITY - Market-B

STOCKHOLDERS' EQUITY - Market-Based Awards (Details) - Amortization of market-based awards	9 Months Ended
	Sep. 30, 2022 USD ($) shares
STOCKHOLDERS' EQUITY
Number of Shares | shares	3,000,000
Grant Date Fair Value | $	$ 5,490,420
Options
STOCKHOLDERS' EQUITY
Number of Shares | shares	1,500,000
Grant Date Fair Value | $	$ 2,579,000
Restricted common stock
STOCKHOLDERS' EQUITY
Number of Shares | shares	1,500,000
Grant Date Fair Value | $	$ 2,911,420

STOCKHOLDERS' EQUITY - Stock-Ba

STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
STOCKHOLDERS' EQUITY
Stock-based compensation expense	$ 922,311	$ 1,292,096	$ 3,208,778	$ 2,765,959
Selling, general and administrative expenses
STOCKHOLDERS' EQUITY
Stock-based compensation expense	916,708	1,292,096	3,185,373	2,750,769
Research and development expenses
STOCKHOLDERS' EQUITY
Stock-based compensation expense	5,603	0	23,405	15,190
Common stock for services
STOCKHOLDERS' EQUITY
Stock-based compensation expense		77,040	53,421	345,679
Common stock
STOCKHOLDERS' EQUITY
Stock-based compensation expense	403,812	440,333	1,345,171	1,000,647
Amortization of market-based awards
STOCKHOLDERS' EQUITY
Stock-based compensation expense	477,700	754,207	1,773,169	1,374,226
Stock options
STOCKHOLDERS' EQUITY
Stock-based compensation expense	23,959	$ 20,516	66,377	$ 45,407
Accrued issuable equity (common stock)
STOCKHOLDERS' EQUITY
Stock-based compensation expense	$ 16,840		$ (29,360)

STOCKHOLDERS' EQUITY - Addition

STOCKHOLDERS' EQUITY - Additional Information (Details)			1 Months Ended				3 Months Ended						9 Months Ended
	Sep. 29, 2022 USD ($) shares	May 13, 2022 USD ($) $ / shares	Aug. 31, 2022 USD ($) shares	Jul. 31, 2022 USD ($) shares	Apr. 30, 2022 USD ($) Y item $ / shares shares	Mar. 31, 2022 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) shares	Mar. 31, 2022 USD ($) shares	Sep. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) shares	Mar. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares	Sep. 23, 2022 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares
STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share) | $ / shares							$ 0.0001						$ 0.0001			$ 0.0001
Gross proceeds from exercise of warrants													$ 3,020,836	$ 5,206,716
Grant date value of warrants					$ 3,657,763
Partial payment of principal balance on promissory note													$ 1,000,000	$ 2,450,000
Grant date value of common stock issued related to consulting services provided								$ 10,261	$ 43,160	$ 186,399	$ 110,000	$ 49,800
Company held shares with Restricted common stock awards | shares													194,704
Company held with restricted common stock awards													$ 439,728
Gross proceeds from exercise of options, transferred from treasury							$ 20,158	28,224
Treasury stock, value							$ 296,222						$ 296,222			$ 0
Treasury stock, shares held | shares							131,162						131,162			0
Weighted average grant date fair value of options (in dollars per share) | $ / shares							$ 1.08			$ 1.55			$ 1.31	$ 0.80
Common stock issued upon exercise of options (in shares) | shares							30,542						66,042
Number of market-based awards vested | shares													0
Risk free rate
STOCKHOLDERS' EQUITY
Warrant measurement input | item					0.0288
Expected term (in years)
STOCKHOLDERS' EQUITY
Warrant measurement input | Y					3.69
Expected volatility
STOCKHOLDERS' EQUITY
Warrant measurement input | item					1
Expected dividend
STOCKHOLDERS' EQUITY
Warrant measurement input | item					0
Promissory Note
STOCKHOLDERS' EQUITY
Number of shares issued (in shares) | shares			94,458
Partial payment of principal balance on promissory note			$ 150,000
Prepaid advance
STOCKHOLDERS' EQUITY
Number of shares issued (in shares) | shares	221,605
Partial payment of prepaid advance in shares of common stock	$ 250,000
Interest expense on prepaid advance	$ 24,658
SEPA
STOCKHOLDERS' EQUITY
Value of shares to be issued		$ 50,000,000													$ 50,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Commitment period (in months)		24 months
Maximum advance value of shares to be issued		$ 5,000,000
Price per share to be issued on Market Price (in percent)		98%
Number of consecutive days		3 days
Ownership Limitation (in percent)		4.99%
Exchange Cap (in percent)		19.90%
Amount of advance notices							$ 350,000						$ 350,000
Number of shares pursuant to SEPA | shares							255,240						255,240
Number of shares issued (in shares) | shares				160,782
Gross proceeds				$ 250,000
Legal and consulting services
STOCKHOLDERS' EQUITY
Shares of common stock issued related to consulting services provided | shares							0						12,000
Grant date value of common stock issued related to consulting services provided							$ 0						$ 53,421
Options
STOCKHOLDERS' EQUITY
Unrecognized stock-based compensation expense							335,308						$ 335,308
Unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period													3 years 2 months 12 days
Amortization of market-based awards
STOCKHOLDERS' EQUITY
Unrecognized stock-based compensation expense							1,605,407						$ 1,605,407
Unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period													1 year 2 months 4 days
Restricted common stock
STOCKHOLDERS' EQUITY
Unrecognized stock-based compensation expense							3,963,192						$ 3,963,192
Unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period													2 years 6 months 10 days
Treasury Stock
STOCKHOLDERS' EQUITY
Gross proceeds from exercise of options, transferred from treasury							$ 68,977	$ 74,529					$ 48,382
Common stock issued upon exercise of options (in shares) | shares							(30,542)	(33,000)					63,542
Common stock
STOCKHOLDERS' EQUITY
Common stock shares issued upon exercise of warrants (in shares) | shares					2,346,525	70,143
Gross proceeds from exercise of warrants					$ 2,933,156	$ 87,679
Warrants to purchase common shares issued | shares					2,346,525
Exercise price (in dollars per share) | $ / shares					$ 1
Shares of common stock issued related to consulting services provided | shares								6,000	6,000	85,000	55,000	20,000
Grant date value of common stock issued related to consulting services provided								$ 1	$ 1	$ 9	$ 6	$ 2

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)		9 Months Ended
	Jun. 15, 2022 USD ($) installment	Sep. 30, 2022 USD ($)	Jul. 08, 2022 USD ($)
Sponsorship Agreement:
Number of installments | installment	3
Second Sponsorship Agreement
Sponsorship Agreement:
Committed sponsorship fees	$ 1,450,000	$ 950,000
Aggregate amount spend on agreement			$ 500,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)						1 Months Ended	9 Months Ended
	Oct. 05, 2023 USD ($)	Apr. 05, 2023 USD ($)	Nov. 01, 2022 USD ($) installment shares	Oct. 06, 2022 USD ($)	Oct. 05, 2022 USD ($) installment	Oct. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Nov. 14, 2022 USD ($)	Dec. 31, 2021 USD ($)
Subsequent Event [Line Items]
Remaining balance on initial Prepaid Advance liability							$ 14,681,934		$ 0
Grant date value							$ 65,143
Restricted common stock
Subsequent Event [Line Items]
Number of shares, granted | shares							150,000
Subsequent event
Subsequent Event [Line Items]
Total consideration					$ 3,500,000
Asset acquisition, consideration transferred, cash payments	$ 500,000	$ 500,000		$ 1,000,000	2,000,000
Equity consideration					$ 1,500,000
Number of installments | installment					4
Cash compensation to lead directors			$ 150,000
Cash compensation to non-lead directors			$ 95,000
Number of shares, granted | shares			37,500
Number of share installments quarterly vested | shares			7,500
Subsequent event | COO
Subsequent Event [Line Items]
Number of installments | installment			4
Equity incentive grants terminated | shares			1,500,000
Subsequent event | CEO
Subsequent Event [Line Items]
Number of installments | installment			4
Number of shares, granted | shares			1,500,000
Subsequent event | CTO | Restricted common stock
Subsequent Event [Line Items]
Number of installments | installment			4
Number of shares eligible to receive upon vesting | shares			100,000
Grant date value			$ 205,000
Subsequent event | Maximum | COO
Subsequent Event [Line Items]
Number of shares eligible to receive upon vesting | shares			1,500,000
Subsequent event | Maximum | CEO
Subsequent Event [Line Items]
Number of shares eligible to receive upon vesting | shares			1,500,000
Subsequent event | Supplemental Agreement to the SEPA
Subsequent Event [Line Items]
Number of shares issued during the period (in shares) | shares						5,153,664
Amount of prepaid advance liability satisfied by issuance of shares						$ 5,850,000
Principal amount of prepaid advance liability satisfied by issuance of shares						5,750,000
Interest amount of prepaid advance liability satisfied by issuance of shares						$ 100,000
Remaining balance on initial Prepaid Advance liability								$ 9,000,000
Subsequent event | Supplemental Agreement to the SEPA | Minimum
Subsequent Event [Line Items]
Purchase price per share | $ / shares						$ 0.99
Subsequent event | Supplemental Agreement to the SEPA | Maximum
Subsequent Event [Line Items]
Purchase price per share | $ / shares						$ 1.84